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Abstract
Breast cancer incidence in the United States is I in 8, and over 90% of breast cancer related
deaths are due to metastases, secondary tumors at a site distant from the primary tumor.
Metastasis formation requires carcinoma cells to navigate through the tumor microenvironment
and invade the surrounding stroma. Migration is a highly orchestrated process in which cells are
guided by both internal signals and signals from the microenvironment. Hence, understanding the
mechanisms that guide cell migration in response to various stimuli in the tumor and stromal
microenvironments is key to developing therapies that prevent tumor cell migration and render
cancer more treatable.
Osmotic and hydrostatic pressure gradients within the extracellular matrix (ECM) drive flow of
interstitial fluid through the ECM. Elevated osmotic pressure, lymphatic collapse, solid stress,
and increased microvascular permeability contribute to elevated interstitial fluid pressure (IFP)
during carcinoma progression, and high intratumoral IFP leads to pressure gradients at the tumor
margin, which drive fluid flow that emanates from the tumor core to drain in the surrounding
stroma.
In this thesis, we explore the effect of interstitial flow (IF) on tumor cell migration. We developed
a microfluidic platform to apply repeatable, robust IF through tissue constructs consisting of
human metastatic breast cancer cells embedded within a 3D collagen type I matrix. We
implemented the microfluidic device to validate CCR7-mediated autologous chemotaxis as a
mechanism that guides downstream migration in response to IF. However, we identified a
separate competing pathway that drives cell migration upstream (rheotaxis). Rheotaxis results
from asymmetry in matrix adhesion stress that is required to balance fluid drag imparted by IF on
tumor cells. Thus, autologous chemotaxis, mediated by chemical transport, and rheotaxis,
mediated by fluid stresses, compete to direct cell migration downstream or upstream in response
to IF. Our results provide insight into mechanotransduction in 3D porous media and into the
mechanisms by which asymmetries in matrix adhesion tension guide cell migration. Furthermore,
our results demonstrate that the consideration of IF is crucial for understanding and treating
metastatic disease.
Key words: Interstitial flow, mechanotransduction, tumor cell migration, microfluidics
Thesis committee:
Thesis advisor: Roger D. Kamm, Professor of Mechanical and Biological Engineering, MIT
Peter T.C. So, Professor of Mechanical Engineering, MIT
Adam C. Martin, Professor of Biology, MIT
3
Acknowledgements
I am fortunate to have had a veritable team of supporters, both social and scientific, to
help me through the entire process culminating in this Ph.D. Foremost, I would like to
acknowledge Prof. Kamm, who is an inspiration as well as a mentor. Despite broad
success and great renown, Roger has maintained humility and approachability, and his
emphasis on dissemination of knowledge, through teaching and collaboration, has
broadened the impact of not only his work, but also the work of the microfluidics and
mechanotransduction communities in general. Working with him as both a student and
teaching assistant has taught me much, not just about designing, running, and analyzing
experiments, but about managing and teaching effectively and for the benefit of diverse
communities of students, scientists, and younger generations of aspiring scientists.
Working with Roger has been a pleasure, and I hope to continue a long and productive
relationship as my career develops and Roger's career continues to thrive.
The completion of this thesis would have been a much more bleak process if it were not
for Kevin Cedrone, Joe Sullivan, David Fenning, Chris Ng, Matt Connors, and Andrej
Lenert. From studying for quals to founding the DRS "seminar" series and our (roughly)
weekly meetings at the Muddy Charles Pub, we went through a lot together, and I can't
wait to see what the future has in store for these guys. I also owe thanks to the ski trip
guys: Mark Goller, Matt Bosso, Nick Strutt, Brady Cullen, and Jeff Schatz. Our annual
trips were both relaxing and reality checks.
Various members of the Kamm Lab have been integral to the completion of my thesis. In
particular Sebastien Uzel has been the ideal lab- and office-mate. We "debriefed" after
nearly every seminar and group meeting, and these discussions were often more valuable
than the seminar itself. Similarly, discussions with Ran Li helped me keep a focus on the
big picture and really forced me to think about the role of microfluidics in the context of
biology and not just microfluidics for the sake of microfluidics. Yannis Zervantonakis,
Levi Wood, and Waleed Farahat trained me and taught me nearly every experimental
technique I know, and these guys are all inspirations in their own right as exceptional
scientists.
Finally, from the infamous reckoning at Target in Sommerville, to cheering me on during
my thesis defense, my family has been with me every step of the way. They go beyond
support to genuine interest in my research, and despite geographical separation, we've
remained close, and we are a genuine team. I could not have completed this thesis
without them. Alexandra German has managed to be my girlfriend, collaborator, friend,
and general ally throughout the whole process, and her honesty (and seemingly infinite
patience for my endless talking about science) has been critical, particularly in the final
stages of completing my thesis. For this and for everything, thank you.
4
Table of Contents
Chapter 1: Introduction and background..................................................................... 10
1.1 Tumor microenvironment in the metastatic cascade ..................................................... 10
1.2 Interstitial flow ........................................................................................................................... 12
1.3 Tumor cell migration.................................................................................................................15
1.4 Chemotaxis .................................................................................................................................. 17
1.5 Mechanotransduction........................................................................................................... 19
1.6 Cell migration directed by external mechanical cues................................................... 22
1.7 Mechanotransduction in 3D............................................................................................... 24
1.8 Focal adhesions in cancer ................................................................................................... 25
1.9 Thesis aims and overview ................................................................................................... 28
Chapter 2: Development of a microfluidic platform for interstitial flow......... 30
2.1 Introduction and review of current devices for investigating tumor cell migration ... 30
2.2 System Design ............................................................................................................................. 32
2.3 Cell and device preparation ................................................................................................. 34
2.4 Establishing interstitial flow .............................................................................................. 34
2.5 Imaging and image processing ............................................................................................ 35
2.6 System design and geometry.........................................36
2.7 Interstitial flow field verification ....................................................................................... 37
2.8 Measuring 3D cell migration within microfluidic devices............................................ 39
2.9 Effect of interstitial flow on cell morphology ................................................................. 41
Chapter 3: Effect of IF-induced autocrine gradients on tumor cell migration......... 44
3.1 Introduction and autologous chemotaxis........................................................................ 44
3.2 Methods for investigating autologous chemotaxis ......................................................... 46
3.3 Effect of cell density on directional migration in response to IF ................................. 46
3.4 Effect of blocking CCR7 on directional cell migration in response to IF......................51
3.5 Interstitial flow increases focal adhesion kinase (FAK) activation ............................. 53
3.6 Effect of Src kinase inhibition on cell migration............................................................54
3.7 IF influences direction of fibrosarcoma cell migration................................................ 55
3.9 D iscussion ..................................................................................................................................... 5 8
Chapter 4: Mechanotransduction of interstitial fluid stresses and effect on tumor
cell migration ........................................................................................................................... 61
4.1 Introduction.................................................................................................................................61
4.2 Profile of stresses imparted on cell by IF ........................................................................ 62
4.3 Methods for investigating mechanotransduction of fluid stresses .............................. 63
4.4 FA protein distribution in 3D............................................................................................ 70
4.5 IF induces FA reorganization and upstream polarization of FA proteins ................ 73
4.6 FA protein polarization occurs via 01-integrin signaling.............................................. 77
4.7 Paxillin is required for upstream actin polarization and protrusion formation..........79
4.8 IF induces paxillin-dependent rheotaxis .......................................................................... 81
4.9 D iscussion ..................................................................................................................................... 8 3
Chapter 5: Conclusions and future work ....................................................................... 86
5.1 Conclusions and contributions............................................................................................ 86
5
5.2 Im plications ................................................................................................................................. 88
5.3 Future research directions .................................................................................................. 90
R eferences................................................................................................................................. 93
A ppendix A - C ell seeding protocol* ............................................................................... 107
Appendix B - Tracking microparticles for verifying IF field.....................................111
A ppendix C - M D A -M B 231 Passage Protocol..............................................................112
A ppendix D - M M P Inhibition w ith A protinin .............................................................. 114
A ppendix E - Blocking Integrins ...................................................................................... 115
6
List of figures
Figure 1. Overview of metastatic cascade..................................................................................10
Figure 2. Biochemical and biophysical factors influence the migration of tumor cells.... 12
Figure 3. Interstitial pressure gradients in solid tumors drive interstitial flow from tumor
associated vasculature to draining lymphatics and venous vasculature in the
p eritum oral strom a..........................................................................................................................14
Figure 4. Chemical factors influence the cellular response to mechanical factors and vice
v e rsa ..................................................................................................................................................... 1 7
Figure 5. Nanoscale architecture of focal adhesion..................................................................19
Figure 6. The focal adhesion kinase interacts with many key signaling molecules and
regulates cell invasion, proliferation, matrix assembly, and cytoskeletal tension.....20
Figure 7. Vinculin is recruited to integrins via two pathways..........................21
Figure 8. Substrate strain induces directional cell migration ................................................ 23
Figure 9. Focal adhesion structure varies in 2D and 3D environments....................24
Figure 10. Assays for investigating metastatic cascade ......................................................... 31
Figure 11. Transwell assay modified for investigating the effects of IF on tumor cell
m ig ratio n ............................................................................................................................................ 3 2
Figure 12. Microfluidic systems for applying interstitial flow ............................................. 33
Figure 13. Microfluidic system for seeding cells and applying interstitial flow..............37
Figure 14. IF flow field verified by particle tracking technique...........................................38
Figure 15. Magnitude of observed velocity and magnitude of velocity predicted by
B rinkm an 's equation ....................................................................................................................... 3 9
Figure 16. Average local deviation between the measured angle of the velocity vector and
that predicted by the FEM (degrees).........................................................................................39
Figure 17. MDA-MB 231 cells migrated within microfluidic devices..............................40
Figure 18. Superimposed confocal reflectance image of cells seeded in 3D collagen I
matrix (blue) and confocal image of GFP expressing MDA-MB-231 cells (green).41
Figure 19. Interstitial flow induces cell alignment to flow streamlines............................ 42
Figure 20. Angle of alignment was quantified by fitting an ellipse to each cell and
plotting a vector from the centroid along the major axis of the ellipse....................42
Figure 21. Effect of interstitial flow on cell morphology ...................................................... 43
Figure 22. Peclet # dependence of autocrine gradients for cells exposed to IF...............45
Figure 23. Interstitial flow influences direction of cell migration. Sample time-lapse
images of a cell migrating in an interstitial flow field. Flow is 3.0 pim/s from top to
b ottom in the im age ........................................................................................................................ 4 7
Figure 24. (A-C) Interstital flow affects cell migration. Although flow had no affect on
migration velocity or cell population motility, it significantly increased the
directionality of migrating cells (*p < 0.05).................................................................... 47
Figure 25. Interstitial flow influences direction of cell migration...................................... 48
Figure 26. Interstitial flow induces a bias in direction of tumor cell migration..............50
Figure 27. Cell density does not have a significant effect on cell speed, motility, or
d irectio n ality ..................................................................................................................................... 5 1
Figure 28. Blocking CCR7 has little effect on motility, speed, or directionality for both
c ell d en sitie s ...................................................................................................................................... 5 2
7
Figure 29. Interstitial flow induces FAK phosphorylation ................................................... 53
Figure 30. FAK phosphorylation is localized to the cell membrane................................... 54
Figure 31. Addition of specific inhibitor of Src kinase. PP2 blocked directional migration
of cells exposed to interstitial flow....................................................................................... 55
Figure 32. Migration behavior for HT1080 .............................................................................. 56
Figure 33. Transport model for demonstrating the effect of cell density on transcellular
autocrine chemokine gradients ............................................................................................ 57
Figure 34. Pericellular morphogen gradients are a function of cell density..................... 58
Figure 35. Confocal reflectance image of collagen gel...........................................................63
Figure 36. Method for processing and segmenting vinculin and actin images...............66
Figure 37. Thickness of mask for measuring vinculin distribution at cell periphery.........68
Figure 38. Method for quantifying matrix structure from CRM images............69
Figure 39. Method for quantifying pericellular matrix architecture.......................70
Figure 40. Interstitial flow induces reorganization of matrix adhesions...........................71
Figure 41. MDA-MB-231 expressing vinculin-GFP fusion protein...................................72
Figure 42. Flow induces FA reorganization............................................................................... 73
Figure 43. Focal adhesion proteins localize to the upstream side of cells exposed to IF. A)
Paxillin, FAK, and FAK 397 are distributed diffusely throughout the cell cytoplasm
but weakly colocalize with actin and vinculin at the cell periphery......................... 74
Figure 44. c-actinin localizes upstream with flow ................................................................... 75
Figure 45. Anti-vinculin antibody demonstrates similar protein expression patterns to
vinculin-G FP fusion protein .................................................................................................. 75
Figure 46. Median slice vs. sum of slices for confocal stacks of vinculin distribution for
cells under flow conditions ..................................................................................................... 76
Figure 47. Focal adhesion reorganization is mediated by P31 integrins............................. 78
Figure 48. IF induces paxillin-dependent protrusion formation at the upstream cell
m em b ran e ........................................................................................................................................... 8 0
Figure 49. Graph showing mRNA level of paxillin in cells treated with control or paxillin
siR N A (n = 3 )......................................................................................................................................8 0
Figure 50. Cortactin localizes to protrusions in the upstream direction for cells exposed to
flow (red arrow, scale bar 10gm)..........................................................................................81
Figure 51. IF induces paxillin-dependent rheotaxis..................................................................82
Figure 52. IF increases migration directionality but does not affect average migration
sp eed .................................................................................................................................................... 8 2
Figure 53. Genistein reduces average migration speed ........................................................... 83
Figure 54. Mechanotransduction induces rheotaxis.................................................................85
Figure 55. Rheotaxis and autologous chemotaxis compete to determine the direction of
cell migration in response to IF ............................................................................................. 88
Figure 56. The competing nature of autologous chemotaxis and rheotaxis suggest the
existence of an escape radius within the tumor microenvironment...........................89
Figure 57. The role of matrix adhesion stress asymmetry suggests similar mechanisms are
responsible for rheotaxis and durotaxis...............................................................................90
Figure 58. Approaches for representing confocal imaging data as computational FEM
d o m a in s ............................................................................................................................................... 9 2
8
List of tables
Table 1. Effect of knocking out various focal adhesion proteins on cell migration...........24
Table 2. Current regulatory status of drugs developed to treat solid tumors by targeting
F A p ro tein s........................................................................................................................................2 7
T able 3. Paxillin prim er sequence................................................................................................... 65
9
Chapter 1: Introduction and background
1.1 Tumor microenvironment in the metastatic cascade
Invasive breast cancer incidence in the United States is approximately 1 in 8, and 39,520
women were expected to die from breast cancer in 2011 (breastcancer.org). Although
detection and treatment of primary breast carcinoma has improved greatly, effective
treatment for metastatic disease remains elusive, and over 90% of breast cancer related
deaths are due to metastases, secondary tumors at a site distant from the primary tumor
(1). In the formation of metastases, tumor cells abandon the native epithelial phenotype
and migrate from the primary tumor to local vasculature as single cells or as a collective
invasive front (2). Cells then enter the blood or lymphatic vasculature through a process
known as intravasation, and systemic circulation carries cells to tissue distant from the
primary tumor (3), where a subset of these circulating tumor cells extravasate and
colonize a secondary tumor (Figure 1) (4). Although much recent work has focused on
characterizing the genetic and molecular expression of genes and proteins specific to
metastatic cells for diagnosis and treatment, little is known about the mechanics and
dynamics of tumor cell dissemination and homing to blood or lymphatic vessels.
Primary tumour
Figure 1. Overview of metastatic cascade. Tumor cells acquire a metastatic, migratory phenotype then
migrate across the basement membrane into the surrounding stromal tissue toward blood or lymphatic
vasculature. Once cells intravasate and enter the vasculature, they are carried to sites distant from the
primary tumor, and upon arrest and extravasation, metastatic cells invade the distant tissue and colonize
metastatic lesions (modified from (5)).
Metastasis formation is a complex, multistage process involving modulation of cell
phenotype, cell migration, and dynamic homeotypic and heterotypic cell-cell interactions
(1). There are various proposed models for carcinoma progression and the formation of
metastases (reviewed by Weigelt et al. (6)), and tumors likely employ more than one
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mechanism in vivo. Furthermore, tumors are heterogeneous and vary from host to host
because of genomic instability (7) and plasticity of invasion mechanism (8), and there is
debate as to the source and onset of the metastatic phenotype (9,10). Tumor cell invasion,
a ubiquitous and rate-limiting step in metastatic disease progression occurs early in tumor
progression and represents a viable target for cancer therapy (11).
Disseminating carcinoma cells navigate through the tumor microenvironment, across the
basement membrane and into the surrounding stroma (Figure 2). Migration is a highly
orchestrated process in which cells are guided both by internal signals and signals from
the microenvironment. Mechanical signals, sensed by integrins (12) and other adhesion
receptors (13), and chemical signals, sensed by chemokine and growth factor receptors
(14), influence the migration of tumor cells. Hence, understanding the mechanisms that
guide cell migration in response to various stimuli in the tumor and stromal
microenvironments is key to developing therapies that prevent tumor cell migration and
render cancer more treatable.
Because it is difficult to isolate the effects of an individual stimulus on cell migration in
vivo, in vitro models have emerged as powerful tools for investigating tumor cell
migration. These reductionist in vitro assays isolate a subset of stimuli on tumor cell
migration, and have greatly enhanced our understanding of the important chemical and
mechanical signals that guide tumor cell migration. In this thesis, we leverage the
potential for mechanistic insight provided by in vitro assays to investigate the migration
of single, metastatic breast carcinoma cells and to determine how interstitial flow, a
diagnostic and prognostic marker for metastatic disease, influences the migration of these
cells.
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Figure 2. Biochemical and biophysical factors influence the migration of tumor cells. Mechanical signals
include stiffness of the ECM, the pore size of the ECM, solid stress, fiber alignment, and fibroblast-
generated matrix tension and microtracks. Chemical signals include autocrine gradients, MMPs, oxygen
tension, and paracrine signals from the vasculature, lymphatics, and stromal cells (e.g., fibroblasts, from
Polacheck et al. (15)).
1.2 Interstitial flow
The ECM is porous and biphasic, comprised of a solid phase bathed in interstitial fluid,
which provides a transport medium for nutrients and signaling molecules (16-18).
Osmotic and hydrostatic pressure gradients within the ECM drive flow of interstitial fluid
through the porous solid phase of the ECM (interstitial flow - IF) (19), and IF convection
enhances transport of large molecules to constitutive cells in vascularized tissue (18).
Elevated osmotic pressure, lymphatic collapse, solid stress, and increased microvascular
permeability contribute to elevated interstitial fluid pressure (IFP) in carcinoma (Figure
3A)(20), and high intratumoral IFP leads to pressure gradients at the tumor margin,
which drive fluid flow that eminates from the tumor core to draining lymphatics or
venous vasculature in the stroma (Figure 3B) (21).
Neoplastic IF induces lymphangiogenesis (19) and altered ECM architecture by
stimulating tumor-associated fibroblasts (22), contributing to an altered tumor stroma.
IFP has long been used as a diagnostic (23) and prognostic (24) indicator, as IFP
increases with tumor mass for adenocarcinoma (25), high IFP in breast cancer correlates
with invasiveness (26), and elevated IFP correlates with probability of metastasis
formation (27). IFP has also been used as an indicator for treatment efficacy (28), as
treatment of breast cancer with radiation (29) or paclitaxel (30) decreases IFP, increasing
tumor oxygenation and rendering the tumor more treatable.
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As tumors progress, local tumoral IFP approaches microvascular pressure (MVP), which
contributes to a low transvascular pressure gradient and reduces transport from the
vasculature to the tumor (31). The effects of IFP on transport have been studied in detail
in the context of drug delivery (20), and reducing IFP has been shown to increase drug
delivery and efficacy (32). However, fluid flow also imparts signals on tumor cells and
constitutive stromal cells (Figure 3). Although transvascular transport is reduced in tumor-
associated vasculature, high intratumoral IFP (up to 30 mmHg (31)) contributes to large
pressure gradients at the tumor margin, resulting in high fluid efflux from the tumor core
and elevated IF velocity magnitude. Chary and Jain determined typical IF speeds to be on
the order of 0.1-2.0gm/s (21). The magnitude of IF velocity depends on the magnitude of
the IFP gradient and the hydraulic conductivity of the tumor, and subsequent work has
indicated that the velocity can reach up to 4.0gm/s (33). Computational models
demonstrate that IF speed is a function of the ratio of interstitial to vascular flow
resistance (34), and when the resistance to IF transport is much greater than the resistance
to vascular transport, IF speed at the tumor periphery can reach as high as 10.0gm/s (35).
Recently, the effects of IFP and IF on the biology of the constitutive tumor cells have
been investigated. Initial experiments found that IF alters tumor cell proliferation (36),
and lowering IFP reduces tumor cell proliferation in mouse models (37), and IF induced
intravasation into lymphatic vasculature in a mouse model (38). In general, the effect of
flow has been divided based on the mode of stimulus generation and transduction.
Chemical signals are generated by gradients in soluble morphogens and chemokines and
stimulate cell growth factor receptors (GFRs) and chemokine receptors. Mechanical
signals are generated by fluid stresses and stimulate cell adhesion receptors such as
integrins.
The convection of soluble signals by interstitial flow provides a host of migration signals
to invading tumor cells by transporting both autocrine and paracrine chemokines (Shieh
et al. review of IF and effects on tumor cell invasion (39)). In recent work by Shields et
al., IF was found to increase the metastatic potential of tumor cells through binding of
self-secreted chemoattractant via the CCR7 receptor (40). This autocrine signaling,
termed "autologous chemotaxis," arises when IF transports secreted ligand downstream,
and the balance between convection and diffusion establishes a Peclet number-dependent
pericellular gradient, which provides a chemotactic signal in the downstream direction
(41). IF also influences fibroblast function, promoting matrix reorganization,
differentiation into myofibroblast phenotype (22), and fibroblast migration (42), and
these mechanisms prime the stromal environment through MMP secretion and Rho-
dependent matrix contraction to promote tumor cell invasion (43).
Computational models have aided in elucidating the effects of IF on the mechanical
microenvironment, and the simulations demonstrate that IF applies stress to matrix fibers,
which can be sensed by the cell through matrix adhesions (44), and IF imparts shear
stress on the cell membrane, the magnitude of which is determined by the arrangement of
matrix fibers (45). Interstitial flow increases the migration of vascular smooth muscle
cells through increased MMP13 expression, mediated by heparan sulfate proteoglycans
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(46). Although this work was performed with vascular smooth muscle cells, syndecan
expression in breast cancer has been demonstrated (47), though it remains to be seen
whether proteoglycans play a role in the tumor cell response to interstitial flow. In
preliminary work, we demonstrated that when CCR7 receptors are blocked, tumor cells
migrate in the upstream migration, and the data suggest that the upstream stimulus is
mechanically-mediated (48).
Although the details of the mechanism guiding cells to migrate upstream has yet to be
verified, recent evidence supports the hypothesis that IF imparts competing stimuli on
migrating tumor cells (49). The flow-induced expression of MMPs (42), further
complicates investigation of IF as a migration cue as the MMPs degrade the matrix,
altering the flow field and pressure distribution around the cell. In glioma cells, fluid
stress activates MMP1 (50), and secreted soluble MMPs could be convected downstream,
degrading matrix on the downstream side of the cell, further activating adhesion
molecules on the upstream side, though that remains to be demonstrated. In this thesis,
we investigate the chemical and mechanical signals imparted by IF on cancer cells and
the crosstalk between these signals. Furthermore, we investigate the details of the
mechanism leading to upstream migration, and in so doing, we explore
mechanotransduction of IF stresses in 3D.
Depth into tumor (mm)
B hyperpermeable
myofibroblast
interstitial flow
cfcc
TF-01
type I Collgenbroblas
blood lymphatic
endothelial cell endothelial cellIk
2
Figure 3. Interstitial pressure gradients in solid tumors drive interstitial flow from tumor associated
vasculature to draining lymphatics and venous vasculature in the peritumoral stroma. A) Pressure profile
for adenocarcinoma in a rat model demonstrates high pressure gradients at the tumor margin. Pressures are
normalized to stromal pressure (pstroma= 0 mmHg, from Chauhan et al. (20)). B) Schematic demonstrating
the direction of fluid flow in a solid tumor. Fluid flow influences chemical gradients (purple) and matrix
architecture (black) through signaling to stromal cells (modified from (51)).
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1.3 Tumor cell migration
Recently developed experimental platforms and computational methods have provided
much insight into the mechanisms by which tumor cells migrate in the surrounding
stroma. In epithelial tissues, cells are tightly connected to their neighbors and form
polarized cell sheets with high levels of E-cadherin expression. During the formation of
metastatic lesions in carcinomas, epithelial cells undergo genetic and epigenetic changes
that induce a phenotypic transition, in which cells lose E-cadherin expression (52),
reducing homophilic cell-cell connections, and express vimentin (53), N-cadherin (54),
and other fibroblastic markers (Reviewed by Thiery (55)). This phenotypic switch is
known as the epithelial to mesenchymal transition (EMT), and results in cells of
epithelial origin acquiring a phenotype more amenable to migration and invasion into the
surrounding tissue. The migratory phenotype is varied and dynamic, with invading cells
migrating individually or collectively and modulating the mechanism of migration with
changes in the stromal properties (review of migration mechanisms by Friedl &
Alexander (8)).
Mesenchymal cell migration is an orchestrated process, requiring ECM remodeling,
extension of protrusions through actin polymerization, formation of new adhesions,
molecular motor-mediated cell contraction, and the release of adhesions at the trailing
edge (Reviewed by Lauffenburger & Horowitz (56) and Ridley et al. (57)). Migration
through 3D matrices is termed invasion, and tumor cell invasion is mediated by
invadopodia, specialized Src-kinase-dependent protrusions that are selectively observed
in metastatic cells and extend into the ECM to probe the proximal chemical and
mechanical microenvironment (58). In general, cell migration is a stochastic process (59),
and in the absence of an external gradient or directional cue, cells migrate randomly.
However, when presented with a directional cue, such as a chemokine gradient, the
internal signaling machinery becomes polarized and cells migrate with directional bias
(60). Although an external directional cue will bias the migration direction of cells, the
cells still migrate stochastically, oscillating between a state characterized by directionally
persistent migration and a stationary state, in which the cell reorganizes the cytoskeleton
and changes its direction of migration (61).
Tumor cell migration direction and speed can be modulated independently by external
signals and by internal cytosolic factors. For example, shallow concentration gradients of
epidermal growth factor (EGF) increased the speed and persistence of MDA-MB-231
breast cancer cells but did not bias the direction of cell migration, while steeper gradients
induced cell migration toward increasing EGF concentration (62). Furthermore, the
molecular machinery that regulates the extension of protrusions and direction of
migration can be modulated independently from signals that govern the rate of migration.
In MTLn3 adenocarcinoma cells, inhibition of P13K decreased cell motility but did not
affect directional bias of protrusion extension toward an EGF gradient, and conversely,
inhibition of cofilin decreased the directional bias of protrusion extension while not
affecting cell motility (63).
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The stochasticity of cell migration and the fact that direction and speed can be modulated
independently complicates the use of end-point migration assays. For example, migration
with high speed and low persistence cannot be distinguished from low speed, highly
persistent migration. This issue is compounded in transwell assays, where only the
number of cells reaching and crossing the membrane is measured, and increased
migration speed with random direction could be confused with directionally biased
migration. Furthermore, there is often significant cell-cell heterogeneity in cell migration
characteristics, and migration statistics are often averaged over a cell population. These
bulk, or population-averaged metrics can obscure aspects of the migratory response that
may be important for understanding the response of tumor cells to various stimuli. These
disadvantages can be overcome by the use of live-cell imaging in microfluidic systems.
For example Haessler et al. used population histograms and scatter plots to identify
subpopulations of cells that respond uniquely to interstitial flow, with downstream
migrating cells moving with high directional persistence and upstream migrating cells
moving faster but with less directional persistence, supporting the hypothesis that flow
imparts simultaneous and competing stimuli to tumor cells (49). With the limitations of
traditional, bulk assays in mind, we developed a microfluidic system to allow imaging of
full time-resolved migration dynamics for each cell in a population to allow maximum
resolution in determining the effects of interstitial flow on tumor cell migration.
A key assumption in many reductionist experiments is that the stimuli, particularly
chemical and mechanical signals, act in parallel. However, the migrating cell acts as a
signal integrator, sensing simultaneous stimuli, activating intracellular pathways, and
responding through organized processes that culminate in the extension of protrusions
and subsequent migration (Figure 4). Furthermore, tumor cells invade stromal tissue
through a variety of mechanisms, and the process of migration is dynamic and a function
of tissue substrate (8). As we look to develop the next generation of assays for tumor cell
migration, it is important to consider the crosstalk between chemical and mechanical
stimuli, and the role it plays in guiding the migration of tumor cells. Interstitial flow
inherently couples mechanical and chemical signals, as flow imparts stresses and alters
local chemical transport. In this thesis, we explore the crosstalk between chemical and
mechanical signals and investigate how this crosstalk contributes to directional regulation
of tumor cell migration in response to IF.
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Figure 4. Chemical factors influence the cellular response to mechanical factors and vice versa. MMP and
matrix secretion modulates the stiffness and pore size of the surrounding matrix, while growth factor
receptor (GFR) activation influences integrin expression and activation. Interstitial flow induces
mechanical signals through fluid shear and pressure stresses, while simultaneously inducing chemical
signals through convection of autocrine and paracrine signaling factors (from (15)).
1.4 Chemotaxis
Traditionally, chemical migratory stimuli, mediated primarily by soluble chemical
signals, have been considered independently of mechanical stimuli. Gradients in soluble
molecules can guide the migration of tumor and stromal cells and modulate cancer
progression (64). Tumor cells and stromal cells sense the local concentration of
chemokines and growth factors through surface receptors, and a recent review highlights
the key factors and pathways involved in chemotaxis in cancer progression (14).
Chemokine receptors are often up-regulated in cancer cells in vivo (64), and both tumor
cells and stromal cells migrate in response to chemokine gradients. Chemokines can be
secreted autologously, released from the matrix, or secreted by stromal cells, and cells
respond to the magnitude of the transcellular chemokine gradient as well as the mean
chemokine concentration (65). Eukaryotic cells amplify gradients intracellularly,
downstream of the chemokine receptors through positive feedback signaling loops and
signal inhibition, resulting in large intracellular gradients in response to external gradients
as small as 2-10% between the anterior and posterior ends of the cell (66), (67).
Protrusion formation is crucial to cell polarization, and the regulation of actin
polymerization is key to directional sensing and migration of tumor cells. Chan et al.
identified two transients in actin polymerization in response to epidermal growth factor
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(EGF) stimulation (68). Subsequent experiments have identified the first transient to be
regulated by PLCy, which activates cofilin, an actin severing protein. Cofilin activation
generates free barbed ends on actin filaments, allowing Arp2/3-mediated actin
polymerization and subsequent dendritic actin network extension (63), (69). This first,
PLCy-mediated transient is required for directional sensing of EGF gradients (70), but
the second transient is PLCy-independent and required for protrusion maturation. Hill et
al. determined that the second transient in actin polymerization is mediated by P13K (71)
and likely involves Rho GTPases such as Ras, Rac, and CDC42. Inhibiting P13K alters
the dynamics of lamellipodia formation but does not prevent directional sensing or biased
protrusion formation (67).
Although much recent effort has been devoted to understanding the mechanistic details of
EGF signaling, and computational models have been developed to simulate signal
transduction from EGFR to actin polymerization (72,73), myriad chemokines and their
cognate receptor counterparts direct tumor growth and dissemination in vivo (14,74). The
chemokine (C-C) motif ligand 21 (CCL21), also known as secondary lymphoid-tissue
chemokine (SLC) and 6Ckine, is preferentially expressed in lymph nodes, bone marrow,
and lung, frequent destinations of breast cancer metastasis (74). Although the ligand and
its cognate receptor, C-C chemokine receptor type 7 (CCR7), were first identified as key
signaling components in dendritic cell homing to lymphatic vasculature (75,76), it has
been shown that CCR7 is significantly upregulated in primary breast tumor tissue
compared to normal mammary gland tissue (74), and CCR7 has been indicated as a
strong marker for axillary lymph node metastases in breast cancer (77). CCR7 and
CCL21 are highly expressed in tumors with lymph node metastasis, and patients with
high CCR7 experienced shorter survival period than those with low expression (78).
Interestingly, CCL21 induces lymphangiogensis, and tumors that express CCL21 have
been shown to evade the immune system and recruit stromal leukocyte populations (79).
Furthermore, a subset of cancer cell lines, including MDA-MB 231, express CCL21 (80)
and CCR7 (81,82), and CCL21 induced transient polymerization of filamentous actin
(74) and increased resistance of MDA-MB 231 to detatchment-induced cell death (83),
and gradients of CCL21 induced directional migration of MDA-MB 231 (74). Because
some tumor cells express CCL21 and migrate in response to gradients of CCL21, the
CCR7-CCL21 pathway acts as an autocrine signaling loop, and gradients of self-secreted
ligand can induce chemotaxis. Shields et al. have demonstrated that such autocrine
gradients can guide chemotaxis in cells exposed to IF. In this thesis, we implement a
microfluidic platform to improve upon the experimental system used previously to study
CCR7-CCL21 autocrine chemotaxis, and we culture cells in a physiologically relevant
matrix to investigate the effect of autocrine gradients on tumor cell migration in response
to interstitial flow.
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1.5 Mechanotransduction
Cell migration is a coordinated process involving protrusion extension, adhesion
formation, cell contraction, and adhesion release (56). Consequently, matrix adhesion
formation and turnover are key steps in regulating migration, and interfering with the
molecular regulators of matrix adhesion is a potential method of halting tumor cell
migration and preventing the formation of metastases (84) (85) (86). Integrins are
tension-sensitive adhesion molecules that mediate cell adhesion and migration in a
variety of ECM materials, including collagen (87). Integrin ligation by the ECM induces
clustering of integrins and localization of various structural and signaling proteins to the
ligation site, forming a reinforced plaque known as a focal adhesion (FA) (88) (Figure 5).
These FA plaque proteins form a 40 nm thick mechanical linkage between the
cytoplasmic integrin tails and the actin cytoskeleton (Figure 5)(89), comprising a tension
sensitive, direct mechanical connection between the (ECM) and the cytoskeleton.
Constitutive FA proteins such as focal adhesion kinase and paxillin serve as key
components in the signaling cascade by which cells transduce mechanical signals into
biological responses (mechanotransduction) (13,88).
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Figure 5. Nanoscale architecture of focal adhesion. The ECM is mechanically connected to the
cytoskeleton through a plaque of FA proteins. The structure is mechanically sensitive, and local force
causes accumulation of various FA plaque proteins (modified from (89)).
Signal transduction pathways that regulate cell survival, migration, and proliferation can
be activated by mechanical force, and FAs act as cellular stress sensors, altering
constitutive FA protein composition and initializing signaling cascades in response to
force-induced deformation of FA structural proteins (90). The focal adhesion kinase
(FAK) is a constitutive signaling element of FAs and regulates myriad cell processes
including cell fate, tissue invasion, matrix assembly, cell mobility and cytoskeletal
tension (91), and elevated FAK expression and kinase activity are correlated with
progression to a highly malignant and metastatic phenotype in human cancer (92).
Increased FAK activity increases tumor cell invasion, and blocking FAK inhibits
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invasion and decreases the formation of metastases in human cancer (92). Consequently,
FAK has been identified as a potential drug target for treating carcinoma (85).
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Figure 6. The focal adhesion kinase interacts with many key signaling molecules and regulates cell
invasion, proliferation, matrix assembly, and cytoskeletal tension. Effects on cell invasion are mediated by
paxillin phosphorylation (Modified from (92)).
FAK binds directly to Pl-integrins (93), and tensile force applied to Pl-integrins induces
a conformational change in the cytoplasmic tail of integrins that promotes FAK binding.
The P1-integrin-FAK complex promotes a FAK conformation that results in
autophosphorylation at tyrosine 397 (FAKY3 97) (92). FAK Y 97 binds to and activates Src
(94), a kinase with broad activity that is upregulated in human carcinoma (95) (Figure 6).
Src further phosphorylates FAK, and the resulting FAK/Src signaling complex regulates
integrin affinity to ECM (96) and integrin-mediated traction forces (95). FAK can be
transphosphorylated at Y397 by growth factor receptors such as EGFR and PDGFR,
leading to formation of the FAK/Src signaling complex, and thus FAK represents an
early convergence of mechanically activated and growth factor activated signaling (92).
Interestingly, blocking FAK reduces motility of cells on 2D substrates and invasion in
3D, and overexpression of Src recovers the losses in motility but not 3D invasion due to
the role of FAK in governing MMP expression (92) (Table 1).
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Figure 7. Vinculin is recruited to integrins via two pathways. Initial adhesion formation is mediated by
talin, and tension induces unfolding of cryptic binding domains that allows vinculin binding. Further
vinculin recruitment is mediated by FAK and requires paxillin phosphorylation. The FAK/Pax/Vin
signaling component of this pathway is required for cell stiffness sensing and durotaxis.
FAKY3 97 recruits and phosphorylates paxillin, a FA protein that forms early in FA
assembly (97). Piconewton forces applied to PI-integrins result in local accumulation of
paxillin (98), and paxillin-containing FAs elongate in the direction of applied force (99).
Paxillin activity and expression is correlated with the formation of metastases in human
carcinoma (100,101). Paxillin is a key regulator of actin polymerization through its
recruitment of Rho and Rac (102), and this regulation of actin, in combination with its
force-sensitivity, has implicated paxillin as a mediator of protrusion formation in
response to applied stress at FAs (103). Because protrusion formation is required for
migration, paxillin has been identified as a critical and necessary component in directing
cell migration in response to mechanical stimuli (104).
Phosphorylated paxillin recruits vinculin to FAs, and vinculin colocalization with 31-
integrin is associated with mechanical strengthening of the ECM-actin adhesion complex
(105). Vinculin, along with a-actinin and 1P-integrins, was one of the first FA proteins
identified that localizes to regions of applied force (106). Vinculin is a scaffold protein
with no known catalytic activity but that binds F-actin, talin, a-actinin, paxillin, tensin,
zyxin, ezrin, pl30Cas, Arp2/3, VASP, and itself (107), and because the globular head
domain binds talin while the tail domain binds F-actin, vinculin mechanically links
integrins (through talin) and actin (108). Vinculin is recruited to integrins via two
pathways (Figure 7); in one pathway, tension across 11-integrins is transmitted to talin,
opening cryptic binding domains in talin and allowing vinculin to bind (109,110). The
second pathway involves tension-mediated FAK autophosphorylation at Y397, which
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induces phosphorylation of paxillin at Y31/Y118 and recruits vinculin to FAs (111).
Although cells can still migrate on 2D surfaces if either pathway is blocked, 3D invasion
and migration in response to mechanical cues requires both pathways(1 12) (113) (Table
1).
As a mechanical link between integrin and actin, vinculin is critical for many cell
processes, and within the last decade vinculin has become widely used as a marker for
local stress magnitude. The concentration of vinculin recruited to an FA increases with
the duration and magnitude of applied force (114) (115), while the residence time of
vinculin at an FA is linearly related to the local traction force (116). Because vinculin
concentrations increases with force, measurement of local fluorescence intensities of
fluorescently tagged or stained vinculin can be used to infer the magnitude of force at a
given adhesion, whether the force is applied externally (90) or is generated internally by
the cell (117). Recently, a vinculin mutant has been developed that uses FRET to give a
real-time measure of stress magnitude within an adhesion (110). In this thesis, we
developed a breast cancer cell line that stably expresses a vinculin-GFP fusion protein,
and by tracking the fluorescence intensity of this protein, we infer local cell-matrix
stresses. Furthermore, we use these fusion proteins along with microfluidic devices to
investigate the role of the P1-integrin/FAK/paxillin/vinculin signaling cascade in
directing cell migration in response to IF.
1.6 Cell migration directed by external mechanical cues
The tension sensitivity of FAs and their role in regulating adhesion formation and
dissolution during cell migration implicate a role for mechanical forces in the regulation
of directional cell migration. Indeed, when cultured on a substrate with a gradient in
mechanical stiffness, cells will migrate toward regions of increased stiffness (durotaxis)
(118), and fluid shear stress regulates directional migration of endothelial cells
(mechanotaxis) (119). Furthermore, durotaxis and mechanotaxis both require FAK
signaling through autophosphorylation at Y397 (120) (121). Durotaxis is thought to result
from a force balance between cell contractile force and adhesion tension: cells exert
greater traction forces on stiffer substrates, and higher traction leads to FA activation,
which induces local signaling pathways that result in protrusion formation and eventual
migration (118). Consistent with this proposed mechanism, cells extend protrusions at
regions of high substrate traction (122), and when strain is applied to a substrate, cells
migrate toward regions of maximum tensile strain, where adhesions are in tension and
FAs are activated( 113) (Figure 8). Although these studies point to a relationship between
force, FA activation, and migration, it remains unclear whether force causes migration
through FA activation and signaling, or if migration is activated through other signaling
pathways, and the migration causes FAs to form at the leading edge. To test this "chicken
and the egg" dilemma, Xia et al. constructed anisotropic surfaces that controlled the
direction of FA growth, and the authors found that cells migrated toward the direction of
elongated vinculin-containing FAs (123,124). These data support the pathway where
force, either applied internally (duortaxis) or externally (mechanotaxis), causes activation
and elongation of FAs through FAK signaling, and FA activation leads to migration
toward the region where matrix adhesions are under maximum tension.
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Figure 8. Substrate strain induces directional cell migration. A microneedle was inserted into the silicone
substrate in close proximity to a fibroblast (black circle) and displaced in the direction indicated by the
black arrow. Within 2hrs, the fibroblast reversed the direction of migration, turning to migrate toward the
region of maximum substrate tension (scale bar 40 Rm, modified from (118)).
Determining the force-sensing mechanism that underlies mechanotaxis and durotaxis is
difficult because knocking out various FA proteins halts migration altogether (Table 1). Of
particular interest in mechanotransduction is the FAK/paxillin/vinculin signaling axis,
which is required for durotaxis (104). Each signal is downstream of 13-integrins, and
knocking out each component has a different effect on cell migration (Table 1).
Interfering with FAK or vinculin not only disrupts migration in response to mechanical
cues, but also reduces 3D invasion (92) (125); however, knocking out paxillin attenuates
durotaxis and migration in response to substrate strain (104), but does not affect the
ability for cells to migrate in 3D (126). Furthennore, silencing paxillin reduces adhesion
strengthening and Rac-dependent protrusion formation at regions of local stress (122)
(126) and blocks durotaxis but not chemotaxis (104). These data taken together implicate
paxillin as the force sensor in governing migration in response to mechanical stimuli. In
this thesis, we examine the role of paxillin in mediating the mechanotransduction of IF
stresses, and specifically, we investigate the FAK/pax/vin pathway required for durotaxis
to determine the role of this stiffness-sensing pathway in governing migration in response
to fluid stresses.
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Table 1. Effect of knocking out various focal adhesion proteins on cell migration.
Effect of knockout on...
FA FA FA 2D 3D Durotaxis Chemotaxis Source
protein formation turnover migration invasion (2D) (2D)
(2D) (2D)
FAK +* X X X X X (127)
(113)
(92)
Paxillin + - - 0 - 0 (127) (126) (104)
Vinculin - 0 + X - 0 (127) (125)
(128)
* = increased # of immature adhesions
0 = no change
X = blocked
1.7 Mechanotransduction in 3D
Much of the current understanding of integrin-mediated mechanotransduction and
stiffness sensing is built from experiments in which cells are cultured on stiff 2D
substrates (129), but high substrate stiffness (glass-69GPa, normal mammary stromal
ECM stiffness -200Pa) influences cell morphology, motility, and cell fate (130).
Furthermore, high substrate stiffness (>5kPa) induces formation of P1-integrin FAs and
favors the metastatic phenotype in mammary epithelial cells (131) (12). Consequently,
the relevance and mechanistic details of force-induced PI-integrin signaling when cells
are cultured in physiologically relevant soft, 3D ECM remain unknown. With the advent
of microfabrication technology and the advancement of tissue engineering techniques and
polymeric ECM mimics, new 3D assays for mechanobiology are providing insight into
mechanotransduction in 3D (132).
Figure 9. Focal adhesion structure varies in 2D and 3D environments. Left, a fibrosarcoma cell cultured on
a 2D collagen coated glass substrate, and stained for vinculin. Punctate focal adhesions can be seen at the
periphery of the cell. Right, the same cell type, also stained for vinculin, showed remarkably different FA
structure when cultured in 3D collagen gel. No noticeable punctate FAs are observed (Scale bar 10pm,
from (133)).
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As discussed above, integrin-based adhesions between cells and stiff 2D substrates are
characterized by punctate FAs; however, these punctate adhesions are absent when cells
are cultured in 3D (134) (Figure 9), and FA proteins like vinculin have different effects on
cell motility in 2D and in 3D (125,133) (Table 1). Experiments in which cells were
cultured in tissue-derived 3D matrices demonstrate that these 3D adhesions are more
physiologically relevant than 2D FAs (135), and much recent work has investigated the
mechanisms underlying the differences in adhesion architecture for cells cultured in 2D
and 3D (136). From the perspective of external stimuli, there are two primary differences
between a 2D substrate that presents a stiff surface with uniform matrix coating and a 3D
fibrillar matrix: ECM stiffness and geometric presentation of adhesion ligands. 3D
matrices are softer (2mg/ml collagen type I gel modulus -328Pa), but importantly,
adhesion ligands are confined to matrix fibers, and substrate geometry is known to
regulate tumor cell invasiveness (137). However, exploring 3D mechanotransduction is
complicated by the mechanics of 3D fibrillar materials (136), in which stiffness is
coupled to porosity and adhesion ligand density, both of which also influence cells (138).
For example, increasing stiffness either requires increasing matrix crosslinking, an effect
that decreases pore size and influences tumor cell invasiveness (139), or increasing
matrix density, which also decreases pore size and additionally presents more matrix
ligand (8).
Although the matrix properties are coupled fundamentally, new techniques are being
developed to analyze cells in 3D. In particular, resolving 3D stresses at FAs for cells on
2D substrates is providing mechanistic insight into how cells apply force (140) (141), and
3D traction force microscopy has revealed that cells exert tensile stresses when cultured
in 3D materials (142). Furthermore, although the technique couples pore size and
stiffness, cells have been shown to durotact in 3D (143). However, mechanistic details
are difficult to discern due to the lack of a proper method to apply force locally to cells
analogous to optical traps used to investigate the molecular underpinnings of
mechanotransduction in 2D, even as 3D techniques are giving rise to more realistic tissue
constructs (144) (145). In this thesis, we implement interstitial flow as a method for
applying force to cells in a 3D construct. By combining this experimental technique with
high-resolution imaging, we explore the architecture of 3D adhesions and how they direct
migration through 3D fibrillar matrices.
1.8 Focal adhesions in cancer
FA proteins are often overexpressed in carcinomas, and because FA-associated proteins
are integral elements of mechanotransduction and cell migration, which in turn is critical
in the metastatic cascade, FA proteins have been investigated as cancer therapeutic
targets (Table 2). Carcinoma progression is associated with desmoplasia, pathologic
deposition of ECM, and integrin expression is modulated in response to the neoplastic
ECM (146), and due to these changes in integrin expression, integrins have been explored
as a therapeutic target for treating various solid tumors (Table 2) (86). Cilengitide, a
synthetic peptide that binds a, integrins was developed as a glioblastoma drug much
lauded in preclinical and early clinical trials (146); however, the drug failed in phase III
as there was no detectable effect compared to control (Table 2). However, other drugs
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have been developed to target intracellular signaling components in the
mechanotransduction cascade. The Src/FAK signaling complex, the signaling nexus of
cell adhesion, migration, proliferation, and apoptosis has been explored as a possible drug
target. Src is overexpressed in carcinoma, and the level of expression correlates with the
probablility of metastasis formation (95), and FAK is also overexpressed in carcinoma,
while phosphorylation at Y397 is an indicator for prognosis (92) (85). Dasatinib (Sprycel
by Bristol Myers Squibb) targets Src and has been approved for treatement of
myelogenous leukemia (146) and has shown promise for treating breast cancer when used
in combination with approved chemotherapeutic agents (Table 2), while multiple drugs are
in development to target FAK(147).
The effect of interfering with paxillin and vinculin in treating carcinoma is similar to the
effect of knocking out the respective protein on 2D and 3D migration (Table 1). Paxillin
expression is correlated with the formation of metastases (100,101), and knocking out
paxillin decreased lung metastases in a mouse model (148). Vinculin, on the other hand,
has been identified as a tumor suppressor (107), and vinculin overexpression reduced
primary tumor formation and metastatic cell dissemination (149-151). Although there are
no current drugs in clinical trials for paxillin or vinculin, understanding the mechanism
by which FA proteins contribute to the metastatic cascade will provide further candidates
for therapeutic intervention. In this thesis, we explore the role of IF in altering FA protein
distribution, and further explore the role of FA proteins in directing the migratory
response of breast cancer cells in response to IF. By establishing connections between FA
protein activity and cell migration, we hope to identify new therapeutic targets that would
interfere with the migration of tumor cells and lower the incidence of metastasis
formation.
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Table 2. Current regulatory status of drugs developed to treat solid tumors by targeting FA proteins.
Drug Target Solid cancers Regulatory status FDA clinical trial identifier** &
references
Cilengitide avP3 Glioblastoma Failed phase III NCT00689221 (146)
av 5 (86)
Breast cancer Phase I NCT01276496
Volociximab a5p 1 Renal Phase I NCT00100685
(antibody) (146)
ATN-161 a5 1 Renal Phase I NCT00131651
(peptide- (146)
based) Breast Reduces growth (152)
and metastases in
mice
Dasatinib Src family Chronic Approved (146)
kinases myelogenous
leukemia
Breast cancer Phase II NCT00371345
Phase II with NCT00820170
paclitaxel
(chemotherapeutic
agent)
Phase I with NCTO 1744652
crizotinib (ALK
inhibitor)
GSK2256098 FAK Breast Phase I NCT01138033
cancer* (147)
PF-00562271 FAK Breast Phase I NCT00666926
cancer* (153)
VS-6063 FAK Ovarian Phase I with NCT01778803
cancer paxlitaxel
(chemotherapeutic
agent)
* Other solid tumors, including head & neck, ovarian, and esophageal.
** from clinicaltrials.gov
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1.9 Thesis aims and overview
1.9.1 Thesis aims
In this thesis, we will explore the role of interstitial flow in the progression of breast
cancer toward a metastatic phenotype. In particular, we examine the chemo-mechanical
crosstalk (Figure 2) that influences cell migration in response to interstitial flow,
advancing current understanding of IF in the tumor microenvironment by considering
fluid stresses in addition to the autocrine gradients that promote autologous chemotaxis.
Investigating the effects of fluid stresses on tumor cell migration requires the
development of an experimental technique that allows application of a predictable and
repeatable IF flow field to tumor cells embedded within a physiologically relevant 3D
matrix, and the system must allow monitoring of the transient migratory response tumor
cells embedded within the matrix. To accomplish these goals, the thesis is divided into
three specific aims:
1. Develop a microfluidic platform for applying interstitial flow to tumor cells
embedded within a physiologically relevant extracellular matrix
2.Investigate the effects of autocrine gradients induced by IF on tumor cell migration
3.Elucidate mechanism of mechanotransduction of IF stresses and determine role of
mechanotransduction in guiding tumor cell migration
1.9.2 Thesis overview
In Chapter 2, the current experimental platforms for investigating interstitial flow and 3D
tumor cell migration are reviewed. Drawing from the literature and limitations in current
platforms, design criteria for a new platform to investigate IF are established. We then
introduce two microfluidic platforms that have been designed to meet these criteria for
investigating the effects of IF on tumor cell migration.
In Chapter 3, the role of chemical transport and autocrine gradients that result from IF are
discussed. In particular, we focus on the CCR7 pathway, which has been implicated in
directing tumor cell migration for metastatic carcinoma cells when exposed to flow. We
discuss the directional cues that autocrine gradients impart to tumor cells, and we
establish parameters that govern when these autocrine signals are dominant and direct
cell migration.
In Chapter 4, we focus on the role of fluid stresses imparted on tumor cells exposed to
flow. In particular, we elucidate the difference in directional stimulus between the
autocrine gradients and fluid stress activated focal adhesion signaling. We further
highlight the consistency between this focal adhesion signaling and durotaxis. We
conclude by discussing the role of paxillin in governing the migration response of cells to
interstitial fluids stresses.
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We discuss future directions and conclusions in chapter 5. In particular, we highlight the
generality of IF and explore examples from the literature to demonstrate other instances
in which IF directs cell morphology and migration. Finally, we wrap up with a discussion
of the mechanism by which tumor cells sense and respond to fluid stresses, and we
compare this mechanism to established mechanisms such as durotaxis and mechanotaxis.
We emphasize that although our experiments employed interstitial flow, the underlying
signaling mechanism is much more general and we hypothesize that the effect of
asymmetric stress distribution in cell adhesions is an important physiologic signal in vivo
beyond regulating cell migration in response to IF.
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Chapter 2: Development of a microfluidic platform for interstitial flow*
2.1 Introduction and review of current devices for investigating tumor cell
migration
Understanding the details and dynamics of metastasis is complicated by the myriad cell
types, signaling molecules, ECM components, and cellular interactions involved in EMT,
migration, and intravasation. Consequently, in vitro systems have been developed to
isolate the effects of an individual stimulus on steps of the metastatic cascade (Figure 10)
(For review of in vitro systems to investigate the metastatic cascade see Polacheck et al.
(15)). Typically these systems involve one or multiple cell types seeded on a surface or in
a gel of reconstituted ECM components (36,40,144,154-161). Microfluidics has emerged
as a powerful tool for manipulating molecular concentrations, molecular gradients, and
physical stimuli to cells seeded in these systems. In particular, soft lithography allows for
the construction of cellular bioreactors with small length scales and sample sizes, rapid
prototyping, and optical properties that allow for live-cell imaging (162,163). Although in
vitro systems have been developed to isolate effects of pressure gradients and flow on
cell physiology, the physiological relevance of these systems is limited by 2D or pseudo-
3D culture, where cells are seeded on a surface and overlaid with a gel(40). Furthermore,
many systems are not designed to allow live-cell imaging to observe cell dynamics and
cellular responses in real-time.
The stochasticity of cell migration and the fact that migration direction and speed can be
modulated independently complicates the use of end-point migration assays. For
example, migration with high speed and low persistence cannot be distinguished from
low speed, highly persistent migration. This issue is compounded in Transwell assays
(Boyden chamber), where only the number of cells reaching and crossing the membrane
is measured, and increased migration speed with random direction could be confused
with directionally biased migration (Figure ii). Furthermore, there is often significant
cell-cell heterogeneity in cell migration characteristics, and migration statistics are often
averaged over a cell population. These bulk, or population-averaged, metrics can obscure
aspects of the migratory response that may be important for understanding the response
of tumor cells to various stimuli. These disadvantages can be overcome by the use of
live-cell imaging in microfluidic systems. For example, Haessler et al. used population
histograms and scatter plots to identify subpopulations of cells that respond uniquely to
interstitial flow, with downstream migrating cells moving with high directional
persistence and upstream migrating cells moving faster but with less directional
persistence (49), an observation that could not be made with previous experiments in a
transwell assay (40). The directional bias of migration is an important in understanding
the effects of IF on tumor cell migration. We developed a system where directional bias
of migration can be observed, and we address the validity of previously established
models in the context of 3D directed cell migration.
* Sections of the introduction for this chapter have been published previously. See (15).
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Figure 10. Assays for investigating metastatic cascade. Micropipette: a pipette is placed in the vicinity of
the cell and a chemoattractant solution is injected into the culture medium establishing a growth-factor
gradient (164). Boyden (165) (or Trans- well) chamber: cells are seeded in suspension in the top chamber
and migrate through the porous filter (black rectangles) in response to a chemokine gradient, which is
established by the different culture medium concentrations in the top and bottom chambers.
Micropatterning (166): cells are seeded on patterns of different geometry, size and surface coatings and
their migration characteristics are monitored. Durotaxis (118): cells are seeded on a substrate of variable
stiffness and respond by changing traction forces, cell spread area, and migration direction. Wound healing
(167): a "wound" is formed on a confluent tumor monolayer, and the wound closure dynamics are
monitored. 3D ECM (168): cells are seeded inside the 3D ECM and migrate depending on the ECM
architecture (stiffness, pore size, and ligand concentration); ECM fibers are outlined with black curved
lines. Microfluidics (48,65,159,169,170): cytokine gradients can be established in a 3D matrix by flowing
different chemokine concentration (Chigh - Clow) solutions in the left and right microchannels; Interstitial
flow can be established by adjusting the hydrostatic pressure (Phigh - Plow) in the left and right
microchannels; streamlines are indicated with dark magenta lines. Micropipette, Boyden chamber and
microfluidics assays enable control of biochemical gradients. Durotaxis, 3D ECM and microfluidics assays
enable control of biophysical forces (ECM stiffness and interstitial flow). Wound healing and
micropatterning assay enable control of intercellular distances, whereas only micropatterning assays enable
control of substrate topography. Growth-factor gradients are indicated by the purple triangles. ECM
stiffness gradients are indicated by the dark brown triangle. Blue arrows indicate direction of tumor cell
migration, and pressure gradients are indicated by the shades of green (Figure and caption modified from
Polacheck et al. (15)).
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Figure 11. Transwell assay modified for investigating the effects of IF on tumor cell migration. Flow is
established by applying a pressure drop across a Matrigel plug in which tumor cells are seeded. After a
given amount of time, the membrane (insert) is removed, and the number of cells that migrated through the
membrane are counted; therefore, the quantification of cell migration is biased by only counting cells that
migrate downstream (modified from (144)).
In order to fulfill the objectives presented above, we need to design an experimental
apparatus in which we can culture cells, subject cells to a repeatable and predictable flow
field, and maintain high cell viability. To ensure experimental repeatability, the system
must be easily fabricated and system variability must be low. The system needs to be
optically transparent and biocompatible to allow imaging and to maintain high cell
viability. The system must be easily transferred from the incubator to imaging stage and
easily sterilized to avoid bacterial and fungal contamination.
In order to improve upon previous devices and provide greater physiological relevance,
cells must be suspended in a 3D matrix of reconstituted ECM components. Consequently,
the system must include a region where cell-matrix suspension can be added and
polymerized. A pressure drop is needed to drive fluid flow through the 3D cell construct,
so the system must be closed to the atmosphere but allow input and outlet ports for sterile
cell media. The geometry of the flow chamber must be simple so the pressure drop
induces a predictable flow field.
2.2 System Design
Soft lithography is an efficient, cheap, and robust technique for fabricating biocompatible
microfluidic devices (171). We have developed two microfluidic systems that are
fabricated using soft lithography and meet the design requirements mentioned above. The
first system, termed the "microinjection device" (Figure 12A) was used for preliminary
investigation into the role of IF on tumor cell migration and is discussed primarily in
Chapter 3. The second system, termed the "high throughput device" (HTD, Figure 12C) is
an improved system, modified from a device developed to study angiogenesis (162). The
HTD was used to study mechanotransduction of fluid stresses, and is discussed primarily
in Chapter 4. However, here we discuss fabrication and implementation of both systems,
which is similar for each device. Consequently, we discuss fabrication and use in general
and highlight differences between the two systems when appropriate.
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The flow system consists of a microfluidic chip, fabricated from polydimethysiloxane
(PDMS), with etched features including a cell culture region and media ports. The PDMS
chip can be autoclaved and is sealed with a glass coverslip to allow for sterile cell culture.
For the microinjection device, media channels are connected to the chip with
polyethelyne tubing, and outlet valves allow aspiration of gas bubbles that may form in
the media channels during thermal equilibration (Figure 12B). For the HTD, media
reservoirs are etched glass, and medium is supplied by a syringe pump (Figure 12D). Both
of the systems are designed so that all components fit on a petri dish for easy
transportation to and from the incubator. These devices are easily fabricated; total
fabrication, sterilization, and surface treatment time for each set of devices is less than 3
days, including all incubation periods, and the number of devices in a set is limited only
by the size of a silicon wafer. Typically 4-6 devices are made at a time.
AC
Figure 12. Microfluidic systems for applying interstitial flow. A) The microinjection device contains a
small central gel region, and is small enough to fit in a standard well of a 6-well plate. B) Flow is applied
by attaching external reservoirs. Reservoirs with large surface area are used to minimize pressure head loss
with flow. C) The HTD contains a gel region that is >4x the size of the microinjection device gel region to
allow more data collection per device. D) Flow is applied by attaching glass reservoirs to the device, and
needles connected to a syringe pump (green tubing) are used to introduce flow (downstream medium
indicated in pink).
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2.3 Cell and device preparation
Microfluidic devices were fabricated using soft lithography in a process that has been
described previously (156). Polydimethylsiloxane (PDMS, Ellsworth Adhesives, MA)
was mixed at 10:1 base: curing agent, poured over a silicon master, and incubated
overnight at 80*C. The PDMS was cut from the silicon master, trimmed, and autoclaved
in water. The devices were then dry autoclaved and dried overnight in an oven at 80*C.
The sterile microinjection devices were then surface activated by plasma treatment for
4min, (Harrick Plasma, Ithaca, NY), coated with Poly-D-lysine (PDL, Sigma-Aldrich, St.
Louis, MO) incubated overnight at 37*C, washed with sterile water, and dried overnight
at 80*C. HTD devices were plasma treated for 4min along with a sterile coverslip,
bonded after treatment, and PDL was injected into each device. The devices were
incubated overnight at 37*C, washed with sterile water, and dried overnight at 80*C.
MDA-MB-231 cells originally derived from a pleural effusion were obtained from the
American Type Culture Collection (Manassas, VA) and were cultured in standard growth
media of lOx DMEM (Invitrogen, Carlsbad, CA) with 10% FBS (Invitrogen). Prior to
seeding devices with collagen gel and cells, microinjection devices and a sterile coverslip
for each device were plasma treated for 4min in order to ensure a strong bond between
the PDMS and coverslip when the device is sealed. Collagen type I (BD Biosciences,
Bedford, MA) solution was buffered with lOx DMEM, titrated to a pH of 8.3-8.9 with
NaOH, and brought to a final concentration of 2mg/ml collagen I in total solution. Cells
were harvested with 0.05% Trypsin/EDTA and centrifuged at 12000RPM for 5min. The
cells were re-suspended in media at the desired concentration, and the suspended cells
were then mixed with collagen I solution to make a final cell density of 6.Ox 105, 2.5xi 05,
or 0.5x 105 cells/(ml total solution). The gel-cell solution was added to microinjection
devices by hand using a micropipette, and devices were sealed with a coverslip. In order
to ensure a tight seal between the PDMS and the coverslip, the gel must be added to the
device and the device must be sealed with the coverslip within 30min of plasma treating
the device and coverslip. For the HTDs, devices are already bound to coverslips, so the
gel-cell solution is injected directly in the gel filling port. The seeded devices were placed
in an incubator at 37*C for 30min to allow the collagen gel to polymerize before adding
media via the surface ports, at a rate slow enough so as not to disrupt the collagen gel. In
order to add media without disrupting the gel, it was important to avoid forming a seal
between the pipette tip and media port in the device, as pressure used to eject media from
the pipette could rupture the gel. A small radius pipette tip (or gel filling tip) was used to
wet the glass coverslip at the bottom of the media port, and surface tension drove the
media through the media channels on either side of the gel region.
2.4 Establishing interstitial flow
Cells were incubated overnight at 37*C and 5% CO2. To apply a pressure gradient,
external media reservoirs were connected to the microfluidic chip. Note: it is critical to
avoid conical reservoirs for reliable flow rates (see appendix). For the microinjection
device, the reservoirs were made from modified Nalgene (Thermo Fisher Scientific,
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Waltham, MA) bottles with Tygon (Compagnie de Saint-Gobain, Paris, France) tubing to
connect the reservoirs to the device. Medium was added to each reservoir at volumes that
established the desired pressure gradient across the gel, and large reservoirs (12.5cm 2
cross sectional area) were employed so that volume changes due to interstitial flow were
less than 0.5% relative to reservoir volume during the course of a 12hr experiment for
3pm/s flow. Devices were allowed to reach thermal equilibrium at 37*C before imaging.
Valves were added to allow aspiration of bubbles that may form during thermal
equilibration, and to prevent media leaking during flow.
For the HTD, glass reservoirs (2mm internal diameter) were cleaned and etched with HCl
overnight before being washed with sterile water and autoclaved. Because of the gel
filling ports that are used to inject collagen gel into the device (156) are open to the
atmosphere, they must be covered with glass during an experiment to avoid local
evaporation and bubble formation. Tygon tubing was connected to syringe needles
inserted into the glass reservoirs. For very short-term experiments (< 4 hrs), clear
polycarbonate single-barbed tube fittings (5/32" inner diameter) with cylindrical cross-
section (McMaster Carr, Elmhurst, IL) were press-fitted into 4mm diameter ports
punched into the microfluidic device. Flow was established, and pressure head was
restored every 20min to avoid significant decays in flow velocity. For short-term
experiments (< 12hrs), upstream reservoirs were connected to a syringe pump to add
medium at an appropriate flow rate (see appendix). Cylindrical glass tubing (6mm outer
diameter, Chemglass, Vineland, NJ) was press-fitted into 6mm diameter ports punched
into microfluidic device. Tygon tubing fitted with luer lock adapters were connected to
syringe needles, which were placed inside of glass tubing Figure 12D). Tubing was then
connected to a 3mL syringe and added to a syringe pump for volumetric control of IF
flow rate (see appendix). For long-term experiments, a second syringe pump was used to
remove medium from downstream reservoirs at the same flow rate as pumped into the
upstream reservoirs.
2.5 Imaging and image processing
Phase contrast images were taken every 15min for 16-24hrs in an environmental chamber
held at 37*C and 5% CO 2. After imaging, 200nm diameter fluorescent microspheres
(Polysciences, Warrington, PA) were added to the media, and fluorescent images were
taken to ensure pressure head establishment and flow had not induced gel rupture.
An FEM model was developed in Comsol Multiphysics (COMSOL, Stockholm, Sweden)
using an imported Auto-CAD file (Autodesk, CA) of the device geometry. The model
determine the fluid velocity vector field by solving Brinkman's equation for flow through
a porous media (Equation 1, 12):
pV -v.V -VP =0
- K -
Equation 1: Brinkman's equation
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Where g is the viscosity of water, K is the permeability, and P is the pressure drop. The
model solved Brinkman's equation for the full 3D geometry of the device in steady state.
The permeability was determined experimentally (see Results) and assumed to be
constant throughout the region of device with collagen gel. The pressure drop was
determined for each experiment by measuring the hydrostatic pressure difference
between the upstream and downstream reservoirs.
For cell alignment quantification, images at given time points were segmented using a
previously described Matlab (The Math Works) script (172). Another in-house Matlab
script fit an ellipse to each segmented cell, and the location of the centroid of each ellipse
was passed to Comsol to determine the local flow velocity vector field. Subsequent
vector analysis and quantification was performed using an in-house Matlab script.
For migration quantification, cells were tracked in time-lapse image sequences using the
manual tracking plug-in for ImageJ (http://rsb.info.nih.gov/ij). An in-house Matlab script
determined migration position and velocity vectors from the ImageJ output. The origin of
the migration vectors was passed to Comsol to determine the local fluid velocity vector.
Further vector analysis, including determining the angle between velocity and migration
vectors, was performed in Matlab using an in-house script. Migration data for each cell in
one device was averaged over the whole cell population (the number of cells in a
population is subsequently denoted by m), and the average migration data for each cell
population was averaged over multiple devices (indicated by n). Statistics were tabulated
using a one-way analysis of variance (ANOVA).
To quantify the flow field, 200nm fluorescent microspheres were added to the cell media
in the upstream reservoir. Microspheres were imaged using fluorescent time-lapse
images. Images were binarized using ImageJ, and an automated tracking algorithm in
IMARIS (Bitplane, St. Paul, MN) was used to track the beads in the binarized time-lapse
images. An in-house Matlab script determined velocity vectors for each bead using the
IMARIS output. The origin of each bead was passed to Comsol to determine the local
velocity vector. Subsequent vector analysis was performed in Matlab.
2.6 System design and geometry
The geometry of each device allows time-lapse imaging to observe the dynamics of the
live cell response (Figure 13). The microinjection system and the HTD consist of two
channels separated by a region containing single cells suspended in collagen I gel. The
device employs post structures to keep collagen gel confined to the center of the device
(156). The region of interest (ROI) imaged during the experiments was the center of the
gel region, and only cells located more than 20pm from the PDMS walls were imaged so
edge effects could be neglected. The gel dimensions of the microinjection device ROI
were approximately 1.25mm transverse to flow, 0.75mm in the direction of flow (does
not include region between posts where flow rate is elevated due to reduced cross-
sectional area) and 0.25mm in depth (Figure 1_3A). The gel dimensions for the HTD were
approximately 14.5mm transverse to flow, 0.9mm in the direction of flow and 0.2mm in
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depth (Figure 13B). For live cell experiments, sub-regions of 0.5mm by 0.5mm at one
depth in the center of the device were imaged to observe the response of cells in 3D
matrix. These regions contained approximately 10 cells at cell concentrations of 5 x 104
cells/ml, 50 cells at 25 x 104 cells/ml, and >100 cells at 60 x 104 cells/ml. By applying a
hydrostatic pressure gradient across the gel region, a consistent flow field is generated.
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Figure 13. Microfluidic system for seeding cells and applying interstitial flow. A) For the microinjection
device, cells are seeded in the central region, and the media channels are connected to external reservoirs to
apply a hydrostatic pressure gradient. P1 ad PO are pressures in the two channels with Pl>PO to generate
flow through the gel. B) HTD implements gel injection ports (red) to introduce collagen gel after the device
is bonded to glass coverslip. These ports must be covered with glass prior to establishing pressure gradient,
which, like the microinjection device, involves hydrostatic pressure to drive fluid flow through the gel. C)
Close up of region indicated in (B). Phase contrast demonstrates cells seeded at 60 x 104 cells/mi.
2.7 Interstitial flow field verification
We used FEM software (Comsol Multiphysics) to solve Brinkman's equation for flow
through porous medium (173) for our system geometry (Figure 14). Pressure boundary
conditions were applied at the inlet and outlet ports of the device. No slip boundary
conditions were applied at all PDMS and coverslip surfaces, including central posts. We
validated the flow field by adding fluorescent microspheres to the bulk fluid, and we
imaged the microspheres using fluorescent time-lapse microscopy (Figure 14).
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Figure 14. IF flow field verified by particle tracking technique A) Superimposed velocity vectors of 200nm
diameter beads, output of FEM, and phase contrast image of the region of interest in the microinjection
device. Green vectors indicate magnitude and direction of tracked beads, and blue vectors indicate local
predicted magnitude and direction of the flow field from the FEM model (scale bar 0.25mm. B)
Superimposed velocity vectors of 200nm beads, output of FEM, and phase contrast image of HTD.
Velocity vectors of tracked beads in red, and computational vectors in red (scale bar 0.25mm). C) Output of
FEM for full HTD demonstrates uniform flow velocity at center of gel region.
We found that the measured velocities were repeatable and agreed with the predicted
velocities (Figure 15). In what follows, each flow field will be referred to by its respective
nominal value, the rounded mean of 0.3 pm/s, 3.0 pm/s, 4.6pm/s respectively. Note that
changes in cross sectional area due to device geometry are responsible for variations from
the mean leading to an observable standard deviation in the model velocity magnitude
and bead tracking magnitude. However, variation in the magnitude of the bead tracking
velocity data is also due to thermal motion of the bead. The measured and predicted
velocity vectors were co-directional (Figure 16). The average angle was calculated by
averaging the local angle between the model and observed velocity vectors; quantifying
the angle in this way allows variation in angle due to device geometry to be neglected.
Furthermore, the angle was measured between 0 and 90* so that the average of a
collection of randomly oriented vectors would be 45*. Consequently, the variation in
angle from the mean leading to the standard error is due to a combination of thermal
motion of the bead, nonunifomities in the gel, and experimental error. Cell responses at 3
different velocity magnitudes, 0.3pm/s, 3.0 m/s, and 4.6gm/s, were quantified to sample
responses in the range of published in vivo values. From the bead tracking data, we
determined the hydraulic permeability of 2mg/mi collagen I gel to be Ix10-1 M2 , which is
similar to previously published values (15).
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Figure 15. Magnitude of observed velocity and magnitude of velocity predicted by Brinkman's equation.
A) Velocity magnitude for microinjection device. Nominal values are labeled on the x-axis. B) Velocity
magnitude for HTD. Nominal values are labeled on x-axis (mean + S.D., **p<0.01 determined by
ANOVA).
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Figure 16. Average local deviation between the measured angle of the velocity vector and that predicted by
the FEM (degrees). Y-axis maximum (45 deg) indicates average value for a random distribution of angles.
2.8 Measuring 3D cell migration within microfluidic devices
MDA-MB 231 human breast carcinoma cells were seeded in a collagen I gel in
microfluidic devices as shown in Fig. 13. The cells were suspended in 3D, and when
incubated with lOng/ml hEGF supplemented growth medium, the cells migrated in 3D
(Figure 17). To quantify the cell migration (Chapters 3 and 4), microfluidic devices were
transferred to a microscope housed in a chamber that maintains 37*C and 5% Co2-
Images were taken every 15min for >8hrs, and cells were tracked in the resulting videos
following the protocol described above. The cell migration tracks were further quantified
to provide information on how various experimental conditions affect cell migration
(Figure 17B-C). The cells degraded the collagen matrix as they migrated, leaving tracks in
the gel during migration, thus suggesting a proteolytically active migration mechanism (
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Figure 18).
Over long periods of time, some cells migrate greater than l00m (Figure 17), which
could bring the cell into contact with the glass or PDMS substrates. Reflectance imaging
allows visualization of these surfaces, and cells in contact with the stiff substrate are
neglected, as we are interested in only cells migrating in 3D. When using phase contrast
to take migration videos, however, determining cells in contact with glass or PDMS is
more difficult. These cells tend to display a distinct morphology that is more spread and
less spindle-like. Cells on 2D surfaces also migrate with much higher speed and lower
directionality. Any cells that fit these criteria and are migrating along glass or PDMS
surfaces are neglected.
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Figure 17. MDA-MB 231 cells migrated within microfluidic devices. A) Cells were tracked over 8hrs by
taking phase contrast images every 15min. Migration tracks are superimposed on the image at t=0 to
demonstrate a typical experiment (6 x 10' cells/ml). Tracks that resulted in net migration toward the top of
the device are colored red, while tracks that migrated downward are colored blue to demonstrate the ability
to discriminate between cells that migrate upstream or downstream when IF is applied (scale bar 70pm). B)
Collapsing the tracks, so all trajectories start at (0,0) provides a method for visualizing patterns during cell
migration. C) Polar histogram of the tracks shown in (A) and (B) demonstrates the number of cells
migrating within in a given direction (radial axis is number of cells).
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Figure 18. Superimposed confocal reflectance image of cells seeded in 3D collagen I matrix (blue) and
confocal image of GFP expressing MDA-MB-231 cells (green). Gap behind cell (red arrow) shows cells
migrate in 3D, degrading matrix during migration (scale bar 25gm).
2.9 Effect of interstitial flow on cell morphology
The microfluidic devices described above were implemented to investigate the effect of
interstitial flow on tumor cell morphology. When exposed to interstitial flow, cells
aligned parallel to flow streamlines (Figure 19). At longer times, cells extended
protrusions and subsequently formed multi-cell strings in parallel with the flow
streamlines (Figure 19B). Cell alignment was quantified by measuring the angle between
the major axis of an ellipse fit to each cell and the local flow velocity vector from an
FEM of the flow field. Each cell in a phase contrast image was fitted with an ellipse, and
the centroid of the ellipse was passed to Comsol to determine the local fluid velocity
vector at the respective location. The dot product between the velocity vector and the
major axis of the ellipse was calculated as a measure of alignment. At longer times, after
48 h, cells extended protrusions and subsequently formed multicell strings in parallel
with the flow streamlines; after 40 h, cells exposed to flow velocities of 3.0 pm/s aligned
with the streamlines of the flow field with 86 ± 7% of cells aligned within 450 of the
local streamline. Cells not exposed to flow remained randomly oriented with only 55 ±
2% of cells within 45* of the local streamline (Figure 20). The time required for alignment
demonstrates that cells were actively responding to a stimulus from the flow and not
simply being stretched by the pressure drop across the gel. Cell alignment with the flow
streamlines is consistent with the work of Levesque and Nerem, who demonstrated that
endothelial cells align in response to 2D shear flow (174).
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Figure 19. . Interstitial flow induces cell alignment to flow streamlines. B) Streamline vectors from FEM
of flow in the device superimposed on a phase contrast image of cells exposed to flow (3 pm/s for 12hrs).
B) Fluorescent image of elongated cells demonstrates the formation of multicell strings after 24hrs (red -
phalloidin. blue - DAPI, flow top to bottom 3gm/s for 24hrs).
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Figure 20. Angle of alignment was quantified by fitting an ellipse to each cell and plotting a vector from
the centroid along the major axis of the ellipse. The dot product between the cell alignment vector and local
streamline vector from an FEM was computed. Over time, a greater percentage of the cell population
aligned to the streamlines (*p <0.05; **p < 0.01 determined by ANOVA).
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IF induced cell alignment to flow streamlines, and to determine whether flow influenced
the elongation of cells, an elongation metric was developed. Elongation is measured as
the ratio of the major axis to the minor axis of an ellipse fit to each cell. We then
determined the percentage of a cell population elongated more than a threshold value of
2. Interstitial flow increased elongation of cells, but the increased elongation was not
apparent until 72hrs after application of flow (Figure 21).
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Figure 21. Effect of interstitial flow on cell morphology. Cells were considered elongated when the ratio of
major axis to minor axis was greater than a threshold value of 2 (*p<0.0 5 determined by ANOVA).
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Chapter 3: Effect of IF-induced autocrine gradients on tumor cell
migration*
3.1 Introduction and autologous chemotaxis
Recent work has demonstrated that interstitial flow leads to CCR7 activation and can
influence breast cancer cell migration even in the absence of lymphatic cells. Shields et
al. developed a modified Boyden chamber assay to investigate the mechanism by which
interstitial flow induces CCR7-dependent cell migration in breast cancer cell cultures.
The authors observed increased metastatic potential in cell populations exposed to flow
and demonstrated the increased metastatic potential was activated through binding of
self-secreted CCL21 ligand to the CCR7 receptor (40). This autocrine signaling
mechanism, called autologous chemotaxis, arises in a flow field where convection
distributes autocrine factors leading to a pericellular concentration gradient, which
provides a chemotactic signal (41). The magnitude of the pericellular autocrine gradient
is governed by molecular diffusion and convection, and the non-dimensional Peclet
number represents the ratio of convective to diffusive transport (Equation 2),
Pe = VL
D
Equation 2. Peclet number
where V is the magnitude of the fluid velocity, L is a characteristic length (for measuring
Pe for pericellular transport, the cell diameter is used as the characteristic length), and D
is the molecular diffusivity of the given molecule in the given medium. For Pe<<1,
transport is diffusion dominated, and autocrine gradients will be insignificant as secreted
ligand diffuses isotropically from the cell surface (Figure 22A). For Pe>>1, transport is
convection dominated, and autocrine chemokines are washed downstream. There exists
an intermediate region, for Pe ~ 1, where transport is neither diffusion dominated nor
convection dominated. In this transport regime, diffusion transports the chemokine
radially outward from the cell and convection transports chemokine downstream at a rate
that allows for the chemokine to bind to cell surface receptors (Figure 22C). Competing
convection and diffusion causes the autocrine chemokine to be highly concentrated at the
downstream surface of the cell, and less concentrated at the upstream surface of the cell.
This pericellular gradient in chemokine concentration results in higher receptor ligation at
the downstream side of the cell, and this differential in receptor binding can lead to
chemotaxis downstream (Figure 22D, 41).
* Sections of this chapter have been published previously. See (48).
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Figure 22. Peclet # dependence of autocrine gradients for cells exposed to IF. A) In the absence of IF,
chemokine secreted by the cell (white) diffuse radially outward. B) With the introduction of flow,
chemokine is washed downstream, but no significant gradient develops. C) At higher Pe #'s, when
convection increases, more chemokine is washed downstream. D) At higher Pe #'s, IF can induce gradients
in ligated CCR7 receptors even if the cell is uniformly secreting CCL21. This differential in CCR7 ligation
can induce chemotaxis downstream (A-C simulation results for FEM assuming no slip and constant flux
boundary condition at cell surface, with uniform flow at the inlet and neutral boundary condition at the
outlet, while symmetry was assumed at the lateral boundaries. Only 1/5 of computational domain is
shown).
Computational modeling confirms Pe-dependent pericellular autocrine chemokine
gradients can arise with physiologically relevant IF flow velocities; however, the
simulations have been limited to modeling single cells suspended in homogenous ECM
(41). Presumably the magnitude and profile of autocrine gradients are a function of cell
density, and as the cell density increases, the assumption that the pericellular autocrine
gradient is independent of paracrine gradients becomes less valid. We employed the
microfluidic system described in Chapter 2 to examine the effects of interstitial flow on
cancer cell morphology and migration and to further investigate autologous chemotaxis
via CCL21 and CCR7.
Consistent with this previous study, we found that cells migrated along streamlines in the
presence of flow; however, we further demonstrated that the strength of the flow field as
well as the cell density determined directional bias of migration along the streamline. In
particular, we found that cells either at high seeding density or with the CCR-7 receptor
inhibited migrate against, rather than with the flow. We provide further evidence that
CCR7-dependent autologous chemotaxis is the mechanism that leads to migration with
the flow, but also demonstrate a competing CCR7-independent mechanism that causes
migration against the flow. Data from experiments investigating the effects of cell
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concentration, interstitial flow rate, receptor activity, and FAK phosphorylation support
our hypothesis that the competing stimulus is integrin mediated.
3.2 Methods for investigating autologous chemotaxis
Cells and devices were prepared as described in Chapter 2.4, flow was applied as in
Chapter 2.5, and images were acquired as in Chapter 2.6 and 2.9. Media were
supplemented with human recombinant EGF at 10 ng/mL (PeproTech). For CCR7
blocking, anti-human CCR7 MAb (R&D Systems) was added to the media at 5 gg/mL.
For immunofluorescent staining to measure FAK activation, cells were exposed to flow
as described above for lhr, before media was replaced with 4% PFA to fix the cells.
During fixation, the pressure head and flow was maintained in experimental devices to
preserve protein expression and activation. Cells were then permeabilized and incubated
with mouse anti-human FAK MAb (Abcam, Cambridge, MA) and rabbit anti-human
PAb FAK(Y397) (Abcam). Cells were subsequently imaged with a confocal laser-
scanning microscope, and laser power and signal gains were maintain at constant level
among all devices. The total intensity of FAK(Y397) was normalized to intensity of FAK
for pixels co-localized to GFP for each cell. Inter-device variability for each condition
was not significant.
3.3 Effect of cell density on directional migration in response to IF
Using time-lapse imaging over 16hr intervals, the center of mass of each cell was tracked
24hrs after seeding and 4hrs after applying interstitial flow (Figure 17, Figure 23). Interstitial
flow did not have a significant effect on cell migration speed, defined as total migration
distance over a given time (Figure 24A). Directionality, also referred to as directional
persistence, is a measure of how straight a cell migrates and has been used previously to
demonstrate the effect of chemokines on cell migration behavior (175). Directionality is
defined as the net migration distance normalized by the total migration distance, and cells
exposed to interstitial flow migrated with increased directionality (0.63±0.073 for
0.3pm/s, 0.61±0.071 for 3.Ojm/s, compared to 0.39±0.071 for control, Figure 24B). Cell
motility, ano'ther metric used to quantify cell response to chemokines, is defined as the
percentage of cells migrating a distance greater than one cell diameter and was unaffected
by flow (Figure 24C). In other words, interstitial flow does not affect the percentage of the
cell population that migrates or the speed at which the cells migrate, but migrating cells
exposed to interstitial flow will migrate a larger net distance in a given time.
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Figure 23. Interstitial flow influences direction of cell migration. Sample time-lapse images of a cell
migrating in an interstitial flow field. Flow is 3.0 Lm/s from top to bottom in the image.
Figure 24. (A-C) Interstital flow affects cell migration. Although flow had no affect on migration velocity
or cell population motility, it significantly increased the directionality of migrating cells (*p < 0.05).
47
Interstitial flow induced a directional bias in cellular migration. Polar histograms of
migration data for a control device and a device with 3.Opm/s flow clearly demonstrate
the effect of flow on the direction of migration vectors (Figure 25). In devices with flow,
cells preferentially migrated along streamlines. To quantify the migration direction of cell
populations, two metrics are presented. The "streamline migration metric" scores cells
with a +1 if they migrate within 450 of a streamline and a -I if they migrate outside of
this zone (Figure 25C). An average score for a cell population of +1 indicates that all of the
cells are migrating along a streamline, a score of 0 corresponds to purely random
migration, and score of -1 indicates that all cells are migrating perpendicular to the
streamline. To determine directional bias of migration along streamlines, a "directional
migration metric" was computed that scored cells with a +1 if they migrated within 450
of a streamline in the downstream direction (subsequently denoted "with the flow") and a
-1 if they migrated within 450 of a streamline in the upstream direction (subsequently
denoted "against the flow") (Figure 25D). A population has an average score of +1 if all of
the cells migrating within 450 of a streamline are migrating with the flow, a score of -I if
all of the cells are migrating against the flow, and a score of 0 if equal numbers of cells
are migrating with and against the flow.
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Figure 25. Interstitial flow influences direction of cell migration. A) Sample data from one control device.
The polar histogram demonstrates distribution of angles of net migration vectors for cells in a population in
one device. Cells in control devices without flow migrate randomly. B) Flow changes the distribution of
migration vector angles. In this sample data from one device, cell migration bias, are against the flow. To
quantify directional bias in cell migration, two metrics were computed: C) The streamline migration metric
is a measure of migration bias along the streamlines, and D) the directional migration metric is a measure
of the upstream or downstream migration bias for cells migrating along streamlines. "X" indicates that cells
not migrating along streamlines are not scored for the directional migration metric.
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Cells seeded at 25x10 cells/ml and exposed to interstitial flow preferentially migrated
along the flow streamlines, with average streamline migration scores of 0.47±0.06 for
0.3gm/s and 0.24±0.04 for 3.0pm/s (mean ± STD, Figure 26A). Of the cells migrating
along the streamline, a greater fraction of the cell population migrated upstream than
downstream and the strength of this upstream bias was a function of interstitial flow rate
(these results were not due to EGF gradients within the device, see Appendix). At an
interstitial flow speed of 0.3pm/s, the average directional migration score was
-0.18+0.15, and at 3.0gm/s directional bias increased further to -0.40±0.08. Cells in
control devices did not preferentially migrate in either direction (Figure 26B). These results
were opposite to those reported by Shields et al. (40) who had observed cells to
preferentially migrate with the flow.
49
A 08
C
0
(n
B
0
0)
C
0
0.4
0
-0.4
1
0.5
0
-0.5
-1
-A-25e4 cells/ml
-+5e4 cells/ml
A 25e4 cells/ml+anti-CCR7
-95e4 cells/ml+anti-CCR7
0 0.3 3.0
Flow Velocity [pm/s]
-- 25e4 cells/m
+5e4 cells/ml
A25e4 cells/ml + anti-CCR7
+5e4 cells/mI +anti-CCR7
-4
0 0.3 3.0
Flow Velocity [pm/s]
Figure 26. Interstitial flow induces a bias in direction of tumor cell migration. "High" and "low" refer to
seeding densities of 25 x 10 4 cells/mL and 5 x 104 cells/ mL, respectively. (A) Streamline migration (see
Fig. 2D for definition) measures the bias in migration along streamlines of a cell population. Cells exposed
to interstitial flow preferentially migrated along streamlines, and this bias is a function of flow rate, cell
density, and CCR7 receptor activity. Blocking CCR7 in a 0.3-pm/s flow field causes a significant decrease
in streamline migration score (P < 0.01). In a 3.0-pm/s flow field, blocking CCR7 has the opposite effect of
increasing streamline migration score, but only at a low cell density (P < 0.05). (B) Directional migration
(see Fig. 2E for definition) demonstrates directional bias of cells migrating along the streamline, positive
directional migration indicates downstream migration, and positive streamline migration indicates cells are
preferentially migrating along the streamline. Cells exposed to interstitial flow preferentially migrated
upstream or downstream as a function of flow rate, cell density, and CCR7 receptor activity. Directional
migration scores become more negative with increasing flow velocity. With active CCR7, increasing cell
density reverses directional bias from downstream to upstream (P < 0.01 for both flow rates), but when
CCR7 is blocked, directional migration scores are more negative and do not depend on cell density. (Mean
± SD was computed by averaging the score for each cell in one device (n > 15) and averaging the score for
three devices at each condition.)
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In order to test for the effect of cell density on directional migration under flow,
experiments were conducted at two different seeding densities, 25x 10 and 5x104
cells/ml. Decreasing cell concentration did not affect the bias for migration along
streamlines in a 0.3 Vm/s interstitial flow field, although a smaller percentage of cells
migrated along streamlines in a 3.Oiim/s interstitial field when seeded at a lower
concentration (Figure 26A), nor did decreasing cell density influence cell migration speed,
motility, or directionality (Figure 27).
A 0.2 25 x 101 cells/mi B 125 C 1
-E 0.15 E 5 x 104 cells/ml 1 0.75
2!: 0.2
Control 0.3pm/s 3.Opm/s Control 0.3pm/s 3.0pm/s Control 0.3pm/s 3.0pm/s
Figure 27. Cell density does not have a significant effect on cell speed, motility, or directionality.
Decreasing cell density did, however, exert a dramatic effect on the direction of
migration, causing a reversal in the directional bias of migration relative to the flow as
indicated by the sign change in the directional migration metric, a result consistent with
Shields et al. (40). At a flow speed of 0.3ptm/s, the average directional migration score
was -0.177±0.15 at 25x10 4 cells/ml but increased to 0.570±0.18 at 5x104 cells/ml. For
3.0gm/s, the average directional migration score was -0.401±0.08 at 25x 10' cells/ml but
increased to 0.307±0.16 at 5x10 4 cells/ml (Figure 26B).
3.4 Effect of blocking CCR7 on directional cell migration in response to IF
In devices seeded at 25x10 4 cells/ml and subject to 0.3gm/s interstitial flow, addition of
CCR7 blocking antibody reduced the bias of migration along streamlines, lowering the
average streamline migration metric from 0.472±0.060 to 0.174±0.070, but had little
effect on cells in a 3.0gm/s flow field (Figure 26A), and blocking had little effect on
migration speed, motility, and directionality (Figure 28A-C). At both interstitial flow
velocities, blocking CCR7 increased directional migration against the flow (Figure 26B).
Interestingly, the combined effect of decreasing cell density and blocking CCR7 resulted
in a flow-rate dependent change in migration bias along streamlines. At 0.3gm/s, the
streamline migration score was reduced from 0.489±0.122 to 0.201±0.031 with the
addition of CCR7 blocking antibody at 5x 104 cells/ml; however, at 3.0 Pm/s, the
streamline migration score increased from 0.088±0.188 to 0.384±0.06 at 5x] 04 cells/ml
(Figure 26A), and there was little effect on cell migration speed, motility, or directionality
(Figure 28D-F).
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In devices seeded at 5x 104 cells/ml, addition of anti-CCR7 blocking antibody completely
negated preferential migration in the direction of flow and in fact, caused preferential
migration against the flow. The average directional migration score dramatically
decreased at both flow velocities, from 0.570±0.12 to -0.420±0.19 at 0.3 gm/s and from
0.307±0.16 to -0.649±0.18 at 3.0gm/s (Figure 26B).
When comparing cell populations at 5x104 cells/ml with CCR7 blocking antibody and
populations at 25x10 4 cells/ml with CCR7 blocking antibody, there are no significant
differences in directional migration bias. These data suggest that addition of the blocking
antibody negates the effect of cell concentration on directional migration bias.
Furthermore, although the effects are not statistically significant, a consistent trend is
observed in the effect of flow rate. At both cell concentrations, increasing the flow rate
from 0.3gm/s to 3.0gm/s increases the percentage of cells migrating along the streamline
and increases the upstream migration bias of cells migrating along the streamline (Figure
26).
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Figure 28. Blocking CCR7 has little effect on motility, speed, or directionality for both cell densities. A-B)
Blocking CCR7 reduces motility and speed, though these effects are not significant when cells are exposed
to flow. C) Blocking CCR7 reduces directionality at lower flow rates. D-E) Blocking CCR7 at lower cell
densities does not influence motility and speed, though the trends are reversed from higher cell density. E)
Effect of blocking CCR7 similar to the effect at higher cell density.
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3.5 Interstitial flow increases focal adhesion kinase (FAK) activation.
In devices seeded at 25x 10 cells/ml, cells exposed to 3.0gm/s flow demonstrated
increased phosphorylation at Tyr-397 in FAK, which is associated with focal adhesion
formation and Src kinase activation (120,176). The relative activation of FAK was
determined by measuring the intensity of immunofluorescent staining for FAK and p-
FAK(Y397) in control devices and in devices exposed to 3.Opm/s flow, and cells exposed
to flow demonstrated a significant increase in p-FAK(Y397) intensity (Figure 29). High
magnification confocal images demonstrate that p-FAK(Y397) is localized to the cell
membrane (Figure 30). Furthermore, there is an upstream bias of p-FAK(Y397), which
will be discussed further in Chapter 4. That flow results in increased FAK
phosphorylation is consistent with data from experiments in which we blocked Src kinase
by introducing specific inhibitor of Src kinase PP2 (177). We found that blocking Src
kinase activity resulted in decreased upstream migration, and cells migrated randomly,
with no biased migration upstream or downstream (Figure 31).
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0 Control 3.0pm/s
Figure 29. Interstitial flow induces FAK phosphorylation. (A and B) Overlay of GFP in green and p-
FAK(Y397) in red for projected confocal z-stacks of (A) a representative control device and (B) a
representative device with 3.0 Vm/s flow. Flow direction is from the top to the bottom of the image.
Although each cell population demonstrated heterogeneity in FAK phosphorylation, on average, cells
exposed to interstitial flow demonstrated increased FAK activation. (C) Normalized intensity ratio of p-
FAK(Y397) to FAK per cell demonstrates increased FAK phosphorylation in cells exposed to flow. (Scale
bar, 30 pm.) Mean ± SEM was computed by averaging total intensity of p-FAK(Y397) to FAK staining for
n > 50 cells in three devices for each condition (*p <0.05 determined by ANOVA).
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GFP FAK(Y397) Merge
Figure 30. FAK phosphorylation is localized to the cell membrane. (A-C) GFP (A), FAK(Y397) (B), and
overlay of GFP in green and FAK(Y397) in red (C) for a single z-slice of cells exposed to 3.0 gm/s flow.
Flow is from top to bottom of image. (Scale bar, 10 gm.)
3.6 Effect of Src kinase inhibition on cell migration.
It has been shown that FAK activates Src kinase (178,179), which modulates traction
forces important for tumor cell migration (180,181). To examine the role of shear stress
induced FA activation on migration in the presence interstitial flow, we introduced the
specific inhibitor of Src kinase PP2 (65). We found that inactivation of Src kinase
blocked directional migration of cells exposed to interstitial flow. For cells seeded at
25x 10' cells/ml, the streamline migration score was not significantly different from 0 for
control, 0.3gm/s, and 3.0gm/s applied flow (Figure 31A). Furthermore, the directional
migration scores at 0.3pm/s and 3.Opmls applied flow did not vary significantly from
control (Figure 31B). Cell migration velocity was unchanged with the addition of PP2, but
cell migration was randomly directed, suggesting that Src kinase is involved with
directional sensing for cells exposed to interstitial flow.
These data are consistent with the CCR7-mediated autologous chemotaxis model for
downstream migration since Src has been implicated in the CCR7 pathway in
lymphocytes (76,182). Since PP2 blocked upstream migration as well, Src is also
apparently involved in upstream migration; furthermore, upstream migration is
independent of cell density, so paracrine and autocrine signaling through chemokine
receptors are unlikely stimuli for Src activation. Consequently, the PP2 data support our
hypothesis that flow induced stress gradients and directed proteolysis lead to directional
bias in integrin activation, FA formation, and subsequent Src activation, stimulating
migration against the flow.
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Figure 31. Addition of specific inhibitor of Src kinase. PP2 blocked directional migration of cells exposed
to interstitial flow. (A) In devices at both flow rates, streamline migration scores were not different from 0.
(B) The directional migration score did not vary from control for both flow rates with the addition of PP2
(Mean ± SD was computed by averaging the score for each cell in one device (n > 15) and averaging the
score for three devices at each condition).
3.7 IF influences direction of fibrosarcoma cell migration
To investigate the generality of the mechanism, we repeated the flow experiments with
HT1080 fibrosarcoma cells. When seeded at 25x104 cells/ml and exposed to 3 m/s flow,
HT1080s migrate at nearly 3x speed of the MDA-MB 231 (mean speed 0.298 jm/min
compared to 0.105 m/min), while directionality was similar between the two cell types
(0.556 for HT1080, 0.608 for MDA 231). Importantly, the HT1080 cells migrated
upstream in response to 3 jm/s flow (Figure 32), though the upstream migration was
slightly attenuated when compared to the MDA-MB 231 data (directional migration
metric 0.25 for HT1080, and 0.4 for MDA-MB 231).
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Figure 32. Migration behavior for HT080. A) Migration tracks for HT1080 cells in response to 33 Rm/s
flow from top to bottom. Tracks with net upstream displacement are labeled in red, while those with net
downstream displacement are in blue. Cells were tracked over 12hrs. B) Polar histogram demonstrates
upstream migration behavior by HTI1080s.
3.8 Model for transcellular autocrine morphogen gradient for multi-cell population.
The effect of interstitial flow on autologous morphogen gradients has been previously
studied in the context of autologous chemotaxis (41), but the computational model
presented considers only one cell in the presence of a flow field. Our results on the effect
of interstitial flow on direction of cell migration demonstrate that migration bias in a cell
population is a function of cell density, and we hypothesize that the cell density
dependence was the result of the interaction between morphogen fields among
neighboring cells.
To determine the effects of cell concentration on autocrine gradients in an interstitial flow
field, a coupled mass and momentum transport FEM model was developed in COMSOL.
The geometry used to model cells in a porous matrix consisted of 5 cells, with each cell
modeled as a sphere with radius of 10pm, and the distance between each cell center was
20pm (Figure 33). Brinkman's equation (Equation 1)(173) was solved for the given
geometry. No-slip boundary conditions were applied at the cell walls, and zero normal
velocity was imposed between cells at the lateral boundary. The inlet velocity was fixed
at 3.0gm/s to match experimental conditions, and the permeability was determined
experimentally (see Chapter 2).
The velocity field determined from Brinkman's equation was then used to solve the
diffusion equation:
C+ V- N - R =0
dt
N = -DVC+v- C
Equation 3. Diffusion equation
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Where C is the concentration of morphogen, N is the molar flux, v is the velocity
determined from Brinkman's equation, D is the diffusivity of the morphogen in the given
medium, and R accounts for addition or consumption of the morphogen due to reaction.
The diffusivity for CCL21 in water was used (41), and a variety of reaction rates were
considered. Constant flux boundary conditions were imposed at cell surfaces, no flux
boundary conditions were imposed at the lateral symmetric boundary between cells, zero
concentration boundary condition was imposed at the inlet, and a zero diffusive flux
boundary condition was imposed at the outlet. Steady state was assumed as we intended
to model the concentration field at long times. The resulting morphogen concentration
fields were exported to Matlab for further analysis of pericellular concentration gradients.
We varied reaction rate from 0 to -0.2s'xC (41) and observed that increased cell density
decreased the relative magnitude of chemokine gradients for these reaction rates.
Figure 33. Transport model for demonstrating the effect of cell density on transcellular autocrine
chemokine gradients. Normalized concentration, with red maximum concentration and blue minimum
concentration. All parameters are the same in both figures, except cell density.
To quantify the pericellular gradient, we used a metric similar to the metric used by
Fleury et al. to determine the pericellular gradient for single cells in interstitial flow (41)
and similar to metrics used in chemotaxis assays (65). The pericellular gradient is defined
as (AC/Cm)x 100, where tIC is the difference in concentration between the downstream
and upstream ends of the cell, and C,. is the concentration at the center of the cell. We
found that as more cells are located upstream, the pericellular gradient decreased (Figure
34). In other words, increasing the cell density introduces more cells upstream and results
in a lower magnitude pericellular autocrine gradient.
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Figure 34. Pericellular morphogen gradients are a function of cell density. A) Pericellular gradients,
defined as (AC/Cm) x 100, can lead to chemotaxis toward increasing concentration of chemokine.
Increasing the concentration of cells increases the number of upstream cells, and these cells contribute to a
decreased transcellular autocrine chemokine gradient. In these data, R = 0, but similar trends are observed
for physiologic reaction rates. B) Absolute concentration of chemokine is a function of cell density. Color
denotes normalized chemokine concentration (C/CMax), blue indicates C/CMax = 0, and red indicates
maximum concentration C/CMax = 1. White circles indicate cells, and cells are aligned with the x-axis of
A to demonstrate the relationship between concentration field and concentration gradient.
3.9 Discussion
Interstitial flow influenced tumor cell migration and, in particular, dramatically affected
the direction of migration. For all culture conditions with interstitial flow, cells
preferentially migrated along streamlines. The relative fraction of the cell population that
migrated along the streamlines, and the upstream and downstream bias along the
streamline was a function of cell density, CCR7 activity, and interstitial flow velocity.
For cells seeded at 5x10 4 and 25x10 4 cells/ml in 3.0pn/s and 0.3pm/s flow fields,
addition of CCR7 blocking antibody decreased the tendency for downstream migration.
These data indicate that the CCR7 receptor is involved in downstream migration and thus
support the findings of Shields et al., who identified the CCR7 chemokine receptor as
critical in the signaling pathway responsible for autologous chemotaxis (40). Autologous
chemotaxis is the result of a flow-induced gradient of an autocrine chemotactic signal
that is detected by the CCR7 chemokine receptor and stimulates migration in the
direction of flow. Our data confirm that CCR7 is involved in tumor cell migration, and
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we provide validation for and the autologous chemotaxis model by demonstrating that
CCR7 is directly involved in downstream migration.
Interestingly, in experiments without the CCR7 blocking antibody, migration direction
was a strong function of cell seeding density. As cell concentration was increased, fewer
cells migrated downstream, and a general tendency for migration in the upstream
direction began to emerge. We expect the density dependence in the direction of cell
migration is the result of the interaction between autocrine and paracrine chemokine
concentration fields. Autologous chemotaxis, as the result of autocrine chemokine
gradients, had previously been studied in the context of single cells (41), but when we
included the effects of neighboring cells in our model, we observed that increasing cell
density decreases the magnitude of the transcellular gradient for cells downstream of
other cells (Figure 34). This is due to the fact that the local effects of a single cell become
overwhelmed by the effects of ligand release from a population of cells. Consequently,
increasing the cell density decreases the autocrine transcellular gradient, attenuating the
signal for autologous chemotaxis, and reducing the tendency for CCR7-mediated
migration downstream. As further validation that high cell concentration results in a
weaker autologous chemotaxis stimulus, the directional migration trends are similar
between cell populations seeded at high cell concentration and cell populations with
blocked CCR7.
When CCR7 is blocked, directional migration scores decrease for all conditions tested.
The decrease in streamline migration scores is pronounced for cells at 5x 104 cells/ml; the
average directional migration score changes sign from positive to negative, reflecting a
shift in migration bias from downstream to upstream. Motivated by the negative
directional migration scores for both cell densities and flow rates when CCR7 is blocked,
we hypothesize that a CCR7-independent stimulus competes with CCR7-dependent
autologous chemotaxis and when CCR7 is inhibited, stimulates cells to migrate upstream.
The relative strength of these two stimuli governs the directional bias in migration for a
cell population and is a function of cell density, interstitial flow rate, and CCR7 receptor
availability.
The streamline and directional migration scores provide insight into the nature of the
CCR7 independent stimulus. Directional migration scores monotonically decrease
(become more negative) with increasing interstitial flow velocity, and this effect is
independent of CCR7 activity and seeding density. In contrast, downstream migration of
cells at low density peaks at a flow rate of 0.3um/s, then decreases at 3.Oum/s. These
data suggest that the CCR7 independent stimulus increases in strength with increasing
interstitial flow velocity. Furthermore, when CCR7 is blocked, the directional migration
score is independent of cell seeding density, suggesting that the strength of the CCR7
independent stimulus is cell density independent. Interestingly, the upstream migration
stimulus persists even at low cell density and flow rate suggesting that the stimulus is
independent of cell-cell interactions.
Cells at a density and flow rate that induce upstream migration demonstrate increased
FAK activation (Figure 29). Because the upstream migration stimulus is independent of
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cell density and a function of flow rate, and the force due to fluid flow is large enough to
induce integrin activation, we hypothesize that the increased FAK activation is due to
flow-induced stress gradients and resulting integrin activation. These stress gradients
presumably lead to a difference in integrin and FA activation, with more activation
upstream, where cell-matrix connections are in tension. We expect that this mechanism
driving upstream migration is similar to that examined by Lo et al., who demonstrated
that a transcellular strain gradient, which presumably results in biased integrin activation
due to the gradient in tension on the integrin receptors, guides cell migration toward
increasing strain (118). Consistent with the hypothesis that flow-induced FAK activation
drives upstream migration, we found that blocking Src kinase with PP2 reduced upstream
migration (Figure 31).
We provide evidence that stress gradients and integrin-mediated FAK activation drive
upstream migration, and these stimuli are a strong function of the dimensionality of cell
culture conditions. We expect that the difference in integrin distribution for cells on a 2D
substrate and in a 3D matrix is primarily responsible for the differences between our data
and previous reports, which have demonstrated polarized activation of FAK downstream
during lamellipodia formation and subsequent downstream migration in endothelial
monolayers (183). Lin & Helmke demonstrated that migration direction is a function of
geometry and confluency and that non-confluent endothelial cells undergo triphasic
mechanotaxis, in which the cells migrate upstream over short time scales before
migrating randomly and eventually migrating downstream, as opposed to endothelial
cells in a confluent monolayer, which migrate downstream immediately upon application
of shear flow (184). In addition to forces on the cell being pressure dominated rather than
shear dominated for cells in 3D, recent work has demonstrated that migration in 3D is
much different than 2D migration, and Fraley et al. have demonstrated that migration in
3D is predominantly governed by pseudopod activity and matrix deformation (133).
Consistent with these data, confocal reflectance data support that cells in our devices are
migrating in 3D, extending pseudopodia and leaving gaps in the matrix at the trailing
edge as they migrate (Figure 18). Further understanding of the mechanism that drives
upstream migration requires rigorous analysis of the fluid stresses imparted by IF on
tumor cells and the effect of these stresses on focal adhesion related signaling.
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Chapter 4: Mechanotransduction of interstitial fluid stresses and effect
on tumor cell migration
4.1 Introduction
In Chapter 3, we investigated how elevated intratumor fluid pressure drives interstitial
fluid flow and alters chemical transport within the tumor, and the altered transport
environment influences tumor cell migration through the generation of autocrine
chemokine gradients(40,48). Equally important, though not as well understood, is the
drag imparted on the ECM and constitutive cells (44) by interstitial fluid, a similar
stimulus to the FA-activating shear stresses generated on endothelial cells (185). With
endothelial cells, shear stress is the dominant mechanical stimulus and induces FAK
activation and cytoskeletal remodeling; however, for cells embedded within porous
media, the ratio of the force due to the pressure drop across the cell length to the total
shear force is inversely proportional to the hydrogel permeability (Equation 8), and the
permeability of the collagen I hydrogel used in this study is small (lxi0 m2 ), resulting
in an integrated pressure force that is >30x the integrated shear force for a 20Rm diameter
cell (Equation 8). To maintain static equilibrium, all fluid stresses imparted on the cell must
be balanced by tension in matrix adhesions. In 2D, the adhesions balancing the fluid drag
on the cell are confined to the basal cell surface, while in porous media, such as breast
stromal ECM, matrix adhesions are distributed across the full 3D cell surface.
Consequently, maintaining static equilibrium requires greater adhesion tension on the
upstream side of the cell to balance fluid stresses. From the reference frame of the cell,
the effect of IF is mechanically equivalent to applying a net outward force at matrix
adhesions on the upstream side of the cell, similar to the net tensile stresses applied by
optical or magnetic trap to study the molecular mechanisms underlying
mechanotransduction (106,186).
In this chapter, we explore the fluid stresses imparted on cells by IF. We demonstrate that
the forces required to balance drag imparted on the cell by IF induce a transcellular
gradient in matrix adhesion tension, and the tensile stresses at the upstream side of the
cell induce FA reorganization and polarization of FA-plaque proteins including vinculin,
paxillin, FAK, FAK 397, and c-actinin. FA polarization leads to paxillin-dependent actin
localization, the formation of protrusions upstream, and rheotaxis. Consistent with the
governing mechanism of durotaxis on 2D substrates, this 3D mechanotransduction occurs
through FAK and requires paxillin. Silencing paxillin does not affect cell migration speed
but does attenuate rheotaxis. IF is present in many tissues in vivo (187), and because FA
polarization and rheotaxis result from a mechanical force balance, this 3D
mechanotransduction mechanism is fundamental to cells embedded within porous ECM.
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4.2 Profile of stresses imparted on cell by IF
The stresses imparted on a cell embedded within a collagen gel can be estimated from
Ganapathy's solution for flow past a sphere embedded within a Brinkman medium(188).
The dimensionless permeability (Equation 4) is defined as:
r = (1+ (PSa
Equation 4. Dimensionless permeability in Ganapathy's notation
where K is the permeability, a is the sphere radius, and $s is the solid fraction of the
medium. From CRM images (Figure 1, we determine js < 1 (4) ~ 0.11 for Figure 35), and
the dimensionless permeability reduces:
Equation 5. Dimensionless permeability in the low mass fraction limit
The total drag on a sphere in a Brinkman medium is given by:
D=Uoap 2.r 1+-+ )+4r 1+)]
Equation 6. Drag on a sphere in a Brinkman's medium as determined by Ganapathy
Where D is the total drag force, UO is the free stream velocity, R is the viscosity of the
fluid medium. The first term in Eq. S3 is the drag force due to the pressure drop across
the sphere, and the second term is due to the viscous shear stress on the sphere surface. In
our system (K=10-1 m 2 , a=10-5m, U0=4.6gm/s), the total integrated drag force due to
pressure is 235pN and the integrated shear force is 16.8pN. Because 0<1 (K=10-13m 2,
a=10-5 gives o=0.0316), the force due to the pressure drop and the force due to the shear
stress scales as:
1 1
DP;hear Dpesr
Equation 7. Scaling of drag on a sphere in low permeability limit
By taking the ratio of the force due to pressure stress to the force due to shear stress, we
find that the force due to the pressure drop across the cell dominates the integrated shear
force:
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Dpresu1 a
Equation 8. Ratio of the force due to pressure drop to the force due to shear
For a sphere with a 10pm radius, and a collagen gel with the permeability of 10" m2
Dpressur/Dshear 3 1-.6.
Figure 35. Confocal reflectance image of collagen gel. Scale bar 30ptm.
4.3 Methods for investigating mechanotransduction of fluid stresses
Device preparation - HTD microfluidic devices were fabricated via soft lithography as
described above, and seeded with MDA-MB-231 cells. Flow was applied as described in
Chapter 2 (60Pa pressure drop for 4.6[tm/s flow). For migration experiments, culture
medium was supplemented with 20ng/ml hEGF (Peprotech) to stimulate cell migration.
Phase contrast images were taken every 15 min for 8 h in an environmental chamber held
at 37 'C and 5% C02.
Drugs and inhibitors - For r1-integrin blocking, cells were re-suspended in growth
medium supplemented with 50tg/ml mouse monoclonal anti- I integrin blocking
antibody (P5D2 Abcam), and 20ptL of cells in blocking medium was mixed with 200gL
of 2mg/mL collagen type I for a final concentration of 5g/mL anti-el integrin antibody
in gel solution. After gelation, growth medium with 5g/mL anti-P1 integrin antibody
was added to hydrate the gel. For MMP blocking experiments, collagen gel was
synthesized as described above with 2 U/mL aprotinin (Sigma) added to gel solution, and
after gelation, growth medium with 10 Units/mL aprotinin was added to hydrate the gel.
To degrade the glycocalyx, growth medium supplemented with 15 U/L heparinase
(Sigma) was added to hydrate the gel after polymerization, and for tyrosine kinase
inhibition, genistein (Sigma) was added to growth medium at a 100pM.
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Transfection and selection - MDA-MB-231 cells stably expressing vinculin-GFP fusion
protein were generated by lipid transfection and neomyocin selection. The vinculin-GFP
plasmid has been described and characterized previously(189) and was a gracious gift of
Prof. Benjamin Geiger (Weizmann Institute of Science), and the plasmid contains a gene
coding for neomyocin, conferring resistance to geneticin (Invitrogen). Cells were grown
to 70% confluence in 24-well plates and a solution of 0.5mL growth medium, I .7VL
Lipofectamine-LTX (Invitrogen), 0.5stg plasmid DNA, 025 [L PLUS (Invitrogen), and
100lL OPTI-MEM (Invitrogen) was added to each well. Control cells were exposed to
the same transfection medium without plasmid DNA. After 12hrs of incubation, the
transfection medium was replaced with 1mL growth medium per well and cells were
incubated overnight. Cells were then transferred to a 6-well plate and incubated in growth
medium until confluent, and growth medium was replaced with selection medium
containing 3mg/ml geneticin (Invitrogen) in growth medium. Cells were incubated for
48hrs in selection medium, passaged, and further incubated for 72hrs in selection
medium. Resistant cells were moved to a T25 culture flask and incubated in growth
medium for 1-2weeks. GFP-expressing cells were selected via FACS and subsequently
cultured in growth medium. siRNA against human paxillin (gtg tgg agc ctt ctt tgg t) was
generously provided as a gift from the Ingber lab (126). Cells were grown to 70%
confluence in 6-well plates and transfected using SiLentFect (Bio-Rad) following
manufacturers protocol. 24hrs after transfection, cells were seeded in microfluidic
devices.
Fixation and imaging - The pressure gradient was monitored and maintained for 4hrs
before the medium was replaced with 4% paraformaldehyde (Electron Microscopy
Sciences) for fixation. The pressure head was maintained with PFA to fix cells in the
flow condition. After fixation, cells were solubilized with 0.1% Triton-X 100 (Invitrogen)
and stained for actin with AlexaFluor-568 phalloidin (Invitrogen), paxillin, FAK,
FAK 39 7 , u-actinin, cortactin, and/or DAPI. Cells were imaged with a laser-scanning
confocal microscope (FV-1000, Olympus).
Image processing - Full z-stacks of single cells were imaged at 60x magnification with a
confocal laser-scanning microscope. Median slices were used for subsequent analysis to
decouple membrane geometry and signal intensity. For actin and vinculin imaging,
images were binarized and the contour of the cell was determined via the Matlab image
processing toolbox. The contour was diluted inward by 2pm to create an annular mask of
the cell periphery. The mask was then applied to the original image, and the resulting
image was an intensity map of fluorophore emission at the cell membrane. The centroid
of the resulting image was determined, and the image was divided into two images each
containing only pixels upstream or downstream of the centroid.
Collagen fibers were imaged via confocal reflectance microscopy by collecting 405nm
wavelength light reflected by matrix fibers. Matrix intensity images were processed by a
similar method to actin and vinculin processing. In brief, contours of vinculin images
were diluted outward to create a mask that was applied to confocal reflectance images.
After the mask was applied to the reflectance image, intensity values are indicative of
64
light reflected by collagen fibers at the cell periphery. The centroid, upstream pixels, and
downstream pixels were determined with a Matlab script.
Paxillin siRNA characterization - RNA was purified using RNeasy mini kit (Qiagen).
qRT-PCR was performed with iScript cDNA synthesis kit (Bio-Rad) and iTaq Sybr
Green Supermix (Bio-Rad) using CFX96 real-time PCR machine (Bio-Rad). 32-
microglobulin controlled for complementary DNA content. Primers for paxillin are:
Table 3. Paxillin primer sequence
Forward Reverse
Human paxillin 5'- 5'-
CTGGCGGACTTGGAGTCTAC CTCCTCCGACAAGAACACAG
-3' G-3'
Human [32- 5'- 5'-
microglobulin GAATGGAGAGAGAATTGAAA CAATCCAAATGCGGCATCTT
AAGTGGAGCA-3' CAAAC-3'
Image processing for FA protien distribution - 3D images of vinculin and actin were
acquired by a laser point-scanning confocal microscope (Olympus FV1000) and
processed to measure the distribution of actin and vinculin at the cell boundary (Figure 36).
Raw images were taken of cells within microfluidic devices at 60x magnification. The
median image in z (half way between the top and bottom of the cell) was extracted in
ImageJ and processed in Matlab. Images were filtered by a 3-pixel mean filter to reduce
noise, and an image intensity threshold was calculated by Otsu's method(190). Pixels
with intensity greater than this threshold were assigned a value of 1, while pixels below
the threshold were assigned a value of 0. Holes in the binary image were defined as
pixels with a value of 0 that cannot be accessed from an image corner without crossing a
pixel of value 1. The pixels within holes in the image were assigned a value of 1 to create
a filled black and white image of the cell. Pixels are identified as perimeter pixels if they
have a value of 1 and share at least one edge with another I-valued pixel and at least one
edge with a 0-valued pixel.
The contour of the image was dilated inward, toward the cell centroid, by an empirically
determined thickness (Figure 37). The resulting mask (Figure 36) was multiplied pixel by
pixel with the original, filtered image. In the resulting image, only pixels at the cell
periphery have nonzero intensity. The centroid of the cell was determine from the un-
dilated, perimeter image, and all pixels on the upstream side of the centroid are labeled
"upstream," while those to the downstream side of the centroid are labeled
"downstream."
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Figure 36. Method for processing and segmenting vinculin and actin images. A) Raw image of MDA-23 1-
VinGFP exposed to 3 pm/s flow (from left to right as indicated by arrow). Confocal point-scanning
microscope is used to take 3D image of cell at 60x magnification, the median in z is used to quantify actin
and vinculin distribution. B) The image is filtered by averaging with a 3-pixel averaging filter. C) The
image is converted to black and white based on a threshold determined by Otsu's method. D) All holes
(pixels of background intensity that cannot be reached by filling from any corner of the image) are filled in
the binary image and the contour of the filled image is determined by identifying non-zero pixels that share
at least one edge connected to another non-zero pixel and at least one edge connected to a background
pixel. E) The image contour is dilated inward (toward cell centroid) by a thickness determined
experimentally (see SI Results). F) The dilated binary boundary image is multiplied pixel by pixel with
filtered image (B) so pixels not on the cell periphery are assigned intensity values of 0. The centroid of the
cell is determined and upstream pixels are defined as those on the upstream side of the centroid while
downstream pixels are defined as those on the downstream side of the centroid. Scale bar is 10 pm.
Determining the appropriate mask thickness for analyzing vinculin distribution at cell
periphery. In order to attenuate the effects of vinculin that is not associated with the
membrane, we created a filter to block all fluorescence intensity that is not at the cell
membrane. We can determine the cell periphery as described in Figure 36, but we need to
determine the thickness of the mask (Figure 36E). Consequently, we diluted the mask from
the cell membrane incrementally, and quantified the results (Figure 37). Ultimately, we
wanted a mask thick enough to capture all of the information at the cell boundary, but not
thick enough to include the nucleus, which would alter our measurement of fluorescence
intensity.
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We calculated the effect of mask thickness on a normalized measure of polarization for a
single cell, and for the whole cell population exposed to flow. The polarization metric is
computed by measuring the average intensity at the upstream and downstream edges of
the cell (I, and 'doi, respectively) for the median slice of a confocal image stack acquired
for each cell:
Polarization = (Up) - (IDown)
((IUp) + (IDown))/2
Equation 9. Polarization metric for measuring distribution of FA proteins
For the single cell, we observed some variation in polarization with mask thickness for
thicknesses less than 20 pixels, but for masks thicker than 20 pixels, the value of
polarization reached a stable value around 0.46 (at 0.11 pm/pixel for these images Figure
37). We repeated this process of incrementally diluting the mask and calculating
polarization for a large subset of the cells exposed to flow (n=95, Figure 37D). A similar
pattern of variation was found for the cell population, and the value of polarization
reached a constant value around 0.23 at a thickness of 12 pixels. The median thickness of
this range over which polarization is constant is 20 pixels, so 20 pixels was chosen as the
thickness of the mask for quantifying vinculin distribution.
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Figure 37. Thickness of mask for measuring vinculin distribution at cell periphery. (A) Raw image of
vinculin distribution in a median slice of a confocal stack of images. Scale bar is 10pm (B) Contours of
various dilations of the cell periphery. Cell boundary indicated in red, and lines toward the cell centroid
indicate periphery dilations of 4, 10, 20, 30, 40, and 50 pixels respectively. C) Polarization for each of the
dilations shown in (B). Dashed lines of a given color reflect the contour of the same color in (B). Although
there is some variation in polarization for small membrane dilations, the value stabilizes after about 20
pixels. D) Population mean polarization ± SEM values for vinculin images of cells under flow conditions
(n=95, m=7). Smaller thicknesses do not capture the intense staining patterns at the cell periphery, while
large thicknesses tend to include intensity variations from the nucleus. Therefore, a thickness of 20 pixels
was chosen as an optimal thickness, as this value reflects the minimum thickness at which the polarization
measurement is stable.
Image processing for collagen fibers - Collagen reflects 408nm light, and collecting
reflected light via confocal reflectance microscopy (CRM) has emerged as a convenient
method for imaging collagen microstructure without the use of fluorescent labels
(191,192). In a similar method to processing the vinculin and actin images, CRM 3D
images of the collagen matrix were acquired and processed in Matlab. The boundary of a
binary image created from the median slice of the vinculin images was created as
described above (Figure 36). However, instead of diluting the perimeter inward to look at
fluorescence intensity within the cell, the perimeter of the vinculin image was diluted
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outward by an empirically determined amount to create a mask for the pericellular matrix
(Figure 38). This mask was applied to the median slice of the CRM images, and upstream
and downstream pixels were defined by the pixels upstream and downstream of the
centroid of the vinculin perimeter image.
Figure 38. Method for quantifying matrix structure from CRM images. (A) Image of vinculin distribution
for the CRM image in (C) used to create a mask for the CRM image. (B) The vinculin image was binarized
to deterimine the cell boundary as demonstrated in Fig. S2A-D, and the cell boundary was diluted outward
from the cell (SI Results) to create a mask for the CRM image in (C). C) Median slice of a CRM stack of
images. The fibrous structures around the cell are the collagen fiber, and a gap between the cell and the
matrix can be seen clearly on the downstream side of the cell. D) The mask from (B) is applied to the CRM
image in (C) to generate an image of the CRM intensity of the local pericellular matrix. The centroid of the
vincUlin image is used to determine Upstream and downstream pixels. Scale bar is 10pim.
Determining the appropriate mask thickness for quantifying pericellular matrix
architecture. CRM images provide detailed information about collagen architecture, and
we employed CRM to determine the effect of interstitial flow on the collagen structure.
To restrict our analysis to the pericellular collagen matrix, we developed a filter to
attenuate reflectance signal within the cell cytoplasm and far from the cell periphery
Figure 38). To ensure our results were not dependent on the mask thickness, we varied the
thickness of the mask and measured polarization for the CRM images (
Figure 47).
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We determined the effect of mask thickness on a single cell, and for the cell population
exposed to flow (Figure 39). For the single cell, we found that polarization reaches a
minimum of -0.27 at 25 pixels. At larger mask thickness, polarization approaches 0 as the
matrix is of similar architecture upstream and downstream far from the cell. We next
quantified the effect of mask stiffness on the mean value of polarization for the cell
population (n=85, Figure 39D), and we found that the polarization varied for thin masks,
reflecting highly variable matrix structure at the cell membrane. For larger thicknesses,
polarization approaches 0, but the value is stable around -0.13 between 4-30 pixels.
Therefore, a thickness of 17 pixels was chosen as an optimal thickness, as this value
reflects the median thickness for which the polarization measurement is stable.
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Figure 39. Method for quantifying pericellular matrix architecture. A) Polarization for contour dilations of
increasing thickness. Polarization reaches a maximum at 25 pixels. At larger value, polarization approaches
0 as the matrix is of similar architecture upstream and downstream far from the cell. D) Population mean
polarization ± SEM values for CRM images of cells under flow conditions. Larger thicknesses approach 0,
but the value is stable between 4-30 pixels. Therefore, a thickness of 17 pixels was chosen as an optimal
thickness, as this value reflects the median thickness for which the polarization measurement is stable.
4.4 FA protein distribution in 3D
For all data presented in Chapter, 4, the HTD was used to increase experimental
throughput by allowing more cells/device than in the microinjection device (
Figure 40A). We introduced a 60 Pa pressure gradient across a 2mg/ml collagen gel to
drive flow with a mean velocity of 4.6[tm/s, measured along the centerline of the device.
The total fluid drag force imparted on a spherical cell can be calculated from the solution
for drag on a sphere within a Brinkman medium(188), and for our experimental setup, a
16.8pN integrated shear force and 235pN integrated pressure force is imparted on each
20pjm-diameter cell (Equation 6).
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Figure 40. Interstitial flow induces reorganization of matrix adhesions. A) Microfluidic platform for
applying interstitial flow (IF) with collagen/cell suspension indicated in pink and cell culture medium
indicated in blue. The gel region is 200pm deep, and a pressure gradient (PI > PO) is established across the
gel region to drive IF (scale bar 2.5mm). B) MDA-MB 231 cells embedded within 2mg/ml collagen gel are
characterized by diffuse distribution of vinculin with regions of high vinculin concentration at the cell
periphery (red arrow, scale bar 8pm), where large collagen fibers are in contact with the cell, as seen in the
reflectance channel. Actin is confined to the periphery of the cell and colocalizes with vinculin. Composite
images, demonstrate that regions of intense vinculin and actin staining correspond to regions where
collagen fibers extend radially outward from the cell surface (red actin, green vinculin, grey reflectance,
scale bar 3pm). C) 4.6 pm/s flow induces vinculin and actin localization at the upstream edge of the cell
(scale bar 9pm). Composite images demonstrate upstream localization of actin and vinculin where the cell
is in contact with collagen (actin red, vinculin green, reflectance grey, scale bar 3pm). D) Colocalization of
vinculin and collagen at the cell membrane, where each data point represents a location on the cell
membrane, Regions where vinculin intensity is greater than the mean (vertical black dashed line) + ISD
(red dashed line) correspond to regions with high reflectance intensity. E) Vinculin accumulates rapidly at
the upstream side of the cell. 16-color intensity histograms (Red=max, blue=min) demonstrate intense
vinculin localization within 4min of 4.6 pm/s flow (scale bar 8pm, inset scale bar 3 pm).
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MDA-MB 231 mammary adenocarcinoma cells embedded within 2mg/mi 3D collagen
type I gels displayed diffuse distribution of vinculin and less prominent punctate vinculin
aggregates than when cultured on 2D glass substrates coated with collagen type I, and F-
actin was localized to the cell periphery rather than traversing the cells in stress fibers as
in 2D (
Figure 40B, Figure 41), and actin colocalized with vinculin (
Figure 42A). When cells were exposed to 4.6m/s flow for 4hrs, vinculin and actin
localized at the upstream edge of the cell, while the density of collagen as measured by
confocal reflectance microscopy was reduced at the downstream edge of the cell (
Figure 40C). The vinculin asymmetry induced by flow is due to an increase in FA-like
vinculin clusters on the upstream side of the cell (
Figure 42B), and these FA-like clusters occur at regions where collagen is
cell surface (
Figure 40D). Vinculin accumulation at regions of stress occurs rapidly (115),
of applying flow vinculin localizes upstream (
bound to the
within 4 min
Figure 40E).
Figure 41. MDA-MB-231 expressing vinculin-GFP fusion protein. A) Fluorescent image of GFP-vinculin
fusion protein demonstrates punctate staining at focal adhesions, consistent with previous reports". B)
Magnified image of focal adhesions. C) Median slice of GFP-vinculin expressing MDA-231 cell in 3D
collagen gel. Staining is more diffuse than 2D, consistent with previous reports'", but regions of vinculin
accumulation can be seen. D) Actin stained for cell in (A) demonstrates typical stress fiber formation. E)
Actin stain for cell in (C). Actin is distributed at the cell boundary in 3D.
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Figure 42. Flow induces FA reorganization. A) Vinculin and actin colocalize at cell membrane. For each
pixel in the cell shown in Figure 1B, the intensity of vinculin was taken as the x-coordinate and actin
intensity the y-coordinate. Each intensity value was normalized by the mean intensity of the respective
channel across the whole cell (Q=Spearman correlation coefficient, p computed using exact permutation
distribution). B) Increase in polarization for vinculin with flow is due to accumulation of brighter pixels at
upstream side of the cell. The x-axis is the fraction of pixels at the upstream side of the cell greater than the
mean + S.D. intensity for the entire cell. The y-axis is the fraction of the cell population with corresponding
bright pixels upstream (histogram, **p<0.0 1). C) For both flow and control, higher polarization values for
vinculin correspond to higher polarization values for actin. For each cell, the polarization value for vinculin
was taken as the x-coordinate, and the polarization value for actin as the y-coordinate (Q=Spearman
correlation coefficient, p computed using exact permutation distribution).
4.5 IF induces FA reorganization and upstream polarization of FA proteins
Integrin-based mechanotransduction involves a cohort of FA plaque proteins that
accumulate at regions of locally applied stress and localize with vinculin and actin. In
particular, adhesions containing paxillin elongate under applied traction (99), and FAK
becomes autophosphorylated at Y397 through binding with P1 integrins in endothelial
cells in response to shear stress (120) and in breast adenocarcinoma cells when exposed
to 3 pm/s IF (48). Furthermore, phosphorylation of FAK at Y397 is required for
invadopodia formation for breast cancer cells (193), and FAKY397 is differentially
expressed in metastatic cervical carcinoma relative to noncancerous epithelium (194).
FAK is required for mechanical stress-induced cell polarization(113), and the FAK-
paxillin-vinculin signaling complex is required for rigidity sensing and durotaxis (104).
To quantify the localization of FA proteins, we defined a metric to measure the
distribution of fluorescently tagged proteins at the cell membrane. The polarization
metric is computed by measuring the average intensity at the upstream and downstream
edges of the cell (Iu and Idown, respectively) for the median slice of a confocal image stack
acquired for each cell (Figure 43):
Polarization = Up) - (own)
((IUp) + (IDown))/ 2
Equation 10. Metric for quantifying polarizaiton of FA proteins
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IF (4.6 pm/s flow for 4hrs) caused a statistically significant increase in polarization for
vinculin (from 0.034±0.013 to 0.209±0.013, mean ± S.E.M.), actin (from -0.033±0.023 to
0.177±0.020), and collagen (from -0.040±0.030 to 0.105±0.025, Figure 43), and for both
control and flow, cells with higher magnitude polarization for vinculin correlated with
high polarization for actin (
Figure 42C). The fraction of the cell population with upstream polarization increased with
flow; 81% of cells exposed to 4hrs of flow displayed polarization values greater than the
mean of the control cells (no flow), and 50.2% displayed values greater than the mean + 1
S.D. of control cells (compared to 48% and 14%, respectively for control). A similar
trend was observed for actin, with polarization of 77% of cells with flow greater than the
mean of the control cells and 33% of cells exposed to flow greater than the mean + 1 S.D.
of control cells (compared to 47.7% and 14%, respectively for control).
Furthermore, flow induced a statistically significant increase in polarization for paxillin
(from 0.027±0.029 to 0.117±0.022), FAK (0.032±0.041 to 0.180±0.036), and FAK 3 97
(0.030±0.033 to 0.228±0.034), indicating that these FA plaque proteins localize to the
upstream cell periphery under flow (Figure 43). IF also induced upstream localization of
a-actinin (Figure 44), an actin crosslinking protein critical for the extension of
lamellipodia in 2D (195) that localizes to regions of traction applied by magnetic trap
(106).
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Figure 43. Focal adhesion proteins localize to the upstream side of cells exposed to IF. A) Paxillin, FAK,
and FAK Y39 7 are distributed diffusely throughout the cell cytoplasm but weakly colocalize with actin and
vinculin at the cell periphery. Flow induces upstream polarization of each protein (scale bar lim). B)
Polarization is measured by the relative upstream fluorescence intensity of each signal at the cell
membrane; +2 is maximum upstream polarization, while -2 is maximum downstream polarization.
Upstream polarization increases for collagen ECM. vinculin, actin, paxillin, FAK, and FAKY397 in cells
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exposed to 4.5pm/s flow. (***p<0.001, **p<0.01, *p<0.05 calculated from Wilcoxon rank-sum test with
>45 cells from >3 devices for each condition).
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Figure 44. a-actinin localizes upstream with flow. A) a-actinin is diffusely distributed throughout the
cytoplasm but colocalizes with actin and vinculin at the cell membrane and polarizes to the upstream
membrane under flow (scale bar 10pm). B) Polarization of a-actinin increases with flow (***p<0.001,
calculated from Wilcoxon rank-sum test with >45 cells from >3 devices for each condition).
To ensure the vinculin-GFP plasmid does not influence the distribution of vinculin within
the cell, we repeated the flow experiments with MDA-MB-231 parental cells. Antibody
staining demonstrated a similar staining pattern for vinculin as the constitutively
expressed plasmid (Figure 45). In the presence of flow, vinculin accumulated at the
upstream side of the cell as determined by antibody staining (Figure 45). Polarization was
significantly different for the cells exposed to 3pm/s flow (Polarization= -0.1991 for
flow, Polarization= 0.0371 for control, p=0.0014), with 80% of the cell population
demonstrating a positive Polarization when exposed to flow, indicating vinculin
accumulation on the upstream side of the cell.
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Figure 45. Anti-vinculin antibody demonstrates similar protein expression patterns to vinculin-GFP fusion
protein. A) Antibody stain for vinculin in MDA-MB-231 cells expressing vinculin-GFP fusion protein
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cultured on collagen coated glass. B) GFP imaging of fusion protein for the cell stained in (A). Insets show
similar staining pattern for antibody and fusion protein. C) Vinculin accumulates at the upstream side of the
cell for MDA-MB-231 parental cells (**p<0.0 1).
Each cell imaged for vinculin distribution was imaged with a confocal laser-scanning
microscope to acquire full 3D distribution of fluorescence intensity. The images are
acquired by defining the top and bottom of the cell and imaging 11 x-y slices between the
top and bottom. Consequently, the 6 1h x-y slice is at the middle of the cell, and we
quantified vinculin, actin, and collagen concentration at this plane. We chose to quantify
the median plane rather than the sum of the 11 planes as to not confuse membrane
geometry with intensity (ie/ a thicker region of a cell would appear more intense in the
sum of the slices). However, we found that vinculin accumulates at the upstream side of
the cell when both the median slice and the sum of the slices are quantified (Figure 46).
Although vinculin accumulates at the upstream side of the cell for both methods
(polarization = 0.194 for the median slice and 0.119 for the sum of slices), the sum is
more variable (S.D. = 0.1761 for median slice and 0.2571 for sum of slices).
Furthermore, the nucleus has a significant effect on the sum of the slices (at the median
slice, we can calculate polarization just at the periphery of the cell to neglect the effect of
the nucleus, but when summing slices, the location of the nucleus, which does not contain
vinculin, contributes to variability in the measurement, Figure 46B).
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Figure 46. Median slice vs. sum of slices for confocal stacks of vinculin distribution for cells under flow
conditions. A) Heat-map of vinculin-GFP intensity for the median slice in a confocal stack of a cell. Blue
indicates minimum intensity while red is maximum intensity. Scale bar is 10pm. B) Heat-map for collapsed
confocal stack of a cell. 11 slices, taken at 1.5pm intervals were summed to create the image. Blue is
minimum, while red is maximum. Large contributions from vinculin accumulated around the nucleus can
be seen by the intense red region near the center of the cell. C) Quantification of polarization for median
slices and the sum of slices for 30 cells under flow. The line plot reflects the histogram of polarization data,
while the bar plot demonstrates mean ± S.E.M. The stack and the median slice both demonstrate vinculin
accumulation on the upstream side of the cell, but the data from the collapsed stack is more variable (S.D.
of 0.2571 for sum and 0.1761 for median).
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4.6 FA protein polarization occurs via P1-integrin signaling
The collagen matrix becomes anisotropically distributed under flow (Figure 43), and it is
possible that the FA plaque protein polarization is a consequence of the dense matrix on
the upstream side of the cell, which presents more adhesion sites than the downstream
matrix. When cells were incubated with aprotinin, a broad MMP inhibitor (196), the
pericellular matrix remained isotropically distributed under flow, but vinculin and actin
still localized upstream, suggesting that cell polarization is not due to matrix remodeling (
Figure 47A-B). Shi and colleagues found a heparan sulfate proteoglycan (HSPG) mediated
increase in smooth muscle cell motility in response to IF (46). We incubated cells with
heparinase to degrade the glycocalyx and applied flow for 4hrs, and we found that actin
and vinculin polarization persisted, suggesting that HSPG-sensed shear stress is not
responsible for polarization (
Figure 47C.). Blocking (1 integrin ligation by treating cells with anti- 1 blocking
antibodies (197) attenuated the polarization of actin and vinculin in response to flow. The
cells remained nearly spherical, and vinculin and actin were distributed evenly around the
cell perimeter even when exposed to flow (
Figure 47D-E), providing further evidence that (1 integrin ligation and signaling is
required for actin and vinculin polarization in response to flow.
Miyamoto et al. determined that tyrosine kinase activity is required for the formation of
mature focal adhesions and for the accumulation of most focal adhesion plaque proteins,
including F-actin, to nascent focal adhesions (88). However, the authors found that
vinculin still localized to 31-integrins in response to integrin ligation even when cells
were treated with genistein, a tyrosine kinase inhibitor. In our experiments, genistein
attenuated the upstream accumulation of actin, FAK, and FAKY3 97 in response to flow
such that no statistical difference was observed in polarization between the static and
flow cases. However, the polarization value for vinculin increased with flow (from -
0.066±0.031 to 0.248±0.033) and 69% of cells demonstrated a polarization value greater
than the polarization mean for the static samples (
Figure 47F-G), demonstrating that vinculin polarization is maintained even in the absence
of tyrosine kinase activity, but tyrosine kinase activity is required for recruitment of
FAK, FAKY3 97, and actin.
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Figure 47. Focal adhesion reorganization is mediated by 1l integrins. A) The MMP inhibitor, aprotinin,
blocks flow-induced ECM remodeling (downstream gaps in the matrix indicated by green arrows).
resulting in isotropically distributed pericellular matrix. B) MMP inhibition by treatment with aprotinin
attenuates polarization of ECM with flow, but vinculin and actin remain polarized and localize upstream
(El control, U flow for all graphs). C) Flow causes vinculin and actin polarization in cells treated with
heparinase, which degrades HPSGs, demonstrating that the upstream focal adhesion and cytosketal
polarization occur independent of the glycocalyx. D) Cells treated with anti-31 integrin blocking antibodies
displayed a spherical morphology with actin and vinculin isotropically distributed at the cell periphery. E)
Anti-n I integrin blocking antibodies attenuate actin and vinculin localization at the upstream cell edge, and
there is no statistically significant difference in polarization of actin and vinculin with and without flow. F)
Genistein, a broad tyrosine kinase inhibitor, reduced polarization of actin, FAK, and FAK"3 ". G) Inhibition
of tyrosine kinase activity with genistein attenuated the polarizing effects of flow on actin, FAK, and
FAK39 , though polarization of vinculin persisted. Scale bars l10 m, >45 cells from >3 devices for each
condition, ***p<0.001, **p<0.01, *p<0.05, calculated from Wilcoxon rank-sum test. tp<O.05, tttp<.O0l
measured vs. equivalent flow case with no drug applied).
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4.7 Paxillin is required for upstream actin polarization and protrusion formation
Paxillin is required for stiffness mechanosensing (111), protrusion formation at regions of
high stress (122), and durotaxis (104), and to evaluate the role of paxillin in upstream FA
polarization and rheotaxis, we treated cells with paxillin siRNA. Treatment with specific
siRNA against paxillin resulted in knockdown of paxillin expression by 80% as
confirmed by immunoblotting (Figure 48A) and qRT-PCR (Figure 49), and no change in
vinculin expression was observed (Figure 48A). Paxillin siRNA induced irregular cell
morphology with increased protrusions and decreased polarization of vinculin and actin
under flow (Figure 48B). Although modest vinculin polarization persisted, flow-induced
polsarization of vinculin was attenuated with paxillin siRNA (0.089±0.033 for paxillin
siRNA with flow vs. 0.256±0.034 for scramble siRNA with flow, Figure 48C), while
paxillin siRNA blocked actin polarization (0.0035±0.055 for paxillin siRNA with flow
vs. 0.207±0.048 for scramble siRNA with flow, Figure 48D), a similar trend to the effect
of blocking tysorine phosphorylation.
Actin polymerization and protrusion formation is required for 3D cell migration, and the
number of protrusions per cell in 2D is an indicator for 3D cell motility of MDA-MB 231
cells (198). Exposing cells to 4hrs of 4.6pm/s flow caused a decrease in protrusion
formation, but cells extended more protrusions in the upstream direction (Figure 48E-F).
The mean circularity (the ratio of the square of the cell perimeter to the cell area,
circularity = I for a circle) decreased from 7.75±0.854 to 4.21±0.461 with flow (Figure
4E). To determine the relative number of protrusions upstream and downstream, we
divided maximum intensity projections of an actin stain into thirds by area and compared
the upstream perimeter to the downstream perimeter (Figure 4F). With flow, the relative
upstream perimeter increased from -0.0353±0.038 to 0.146±0.046, and these actin-rich
upstream protrusions colocalize with cortactin (Figure 50), a marker for cell polarity and
the leading edge for 3D cell migration(199). For both control and flow conditions,
paxillin siRNA significantly increased the number of protrusions (circularity of
10.552±8.297 for control and 9.863 for flow), and interestingly, there was no observable
upstream protrusion bias for cells treated with paxillin siRNA (relative circularity of -
0.0471±0.036 for flow compared to 0.007±0.043 for control).
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Figure 48. IF induces paxillin-dependent protrusion formation at the upstream cell membrane. A)
Immunoblots showing paxillin, vinculin and GAPDH protein levels in MDA-MB-231 cells transfected with
scramble control or paxillin-targeted siRNA. B) Cells treated with paxillin siRNA demonstrate isotropically
distributed actin, and vinculin-containing adhesions localize both upstream and downstream. C, D) Paxillin
siRNA attenuates polarization of vinculin (C) and completely blocks polarization of actin (D). E) Paxillin
siRNA increases the number of protrusions for both control and flow as measured by circularity, a
nondimensional measure of the square of cell perimeter normalized by cell area (=1 for a circle). F)
Maximum actin intensity projections of a cell exposed to flow for 4hrs. Actin is more densely localized at
the upstream membrane than on the downstream (left, scale bar 10gm). Magnified images of the upstream
and downstream 1/3r of the cell as measured by area demonstrate more protrusions at the upstream cell
membrane for cells exposed to flow, including larger protrusions indicated by red arrow and slender
filipodia-like protrusion indicated by blue arrow (right, scale bar 5pm). Cells treated with paxillin siRNA
demonstrate more protrusions with no directional bias (left scale bar 10gm, right 5pm). G) The difference
in perimeter between the upstream and downstream 1/3'd of each cell area (as depicted in (F)) demonstrates
that under flow more protrusions form in the upstream direction, and paxillin siRNA attenuates the
upstream protrusion bias (>45 cells from >3 devices for each condition, ***p<0.001, **p<0.01, *p<0.05,
calculated from Wilcoxon rank-sum test. tp<0.05. ttp<0.01 measured vs. control).
z
E
.=Xi
x
IL
1.2-
1 -
0.8-
0.6-
0.4-
0.2-
p=0.0013
siRNA Paxillin
Figure 49. Graph showing mRNA level of paxillin in cells treated with control or paxillin siRNA (n=3).
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Figure 50. Cortactin localizes to protrusions in the upstream direction for cells exposed to flow (red arrow,
scale bar 10pm).
4.8 IF induces paxillin-dependent rheotaxis
IF has been shown to induce rheotaxis when cells are seeded at sufficiently high density
for paracrine chemokine fields to interfere with autocrine chemokine fields (Chapter 3),
and cells migrating upstream have been shown to migrate with increased persistence (49).
We seeded cells at a density shown to induce preferential upstream migration of MDA-
MB 231 (6x 105 cells/ml) and applied 4.6gm/s flow for 8hrs, tracking the cells by taking
images every 15min. Cells preferentially migrated upstream (Figure 51A) with increased
directionality (net migration distance normalized by total migration distance, Figure 52)
though migration speed was unaffected by flow (Figure 52). Paxillin siRNA attenuated
upstream migration (Figure 51B) and reduced flow-induced increases in directionality
(Figure 52), but migration speed was unaffected by paxillin silencing (Figure 52). The use of
genistein did, however, attenuate migration speed (Figure 53).
To further evaluate the effect of flow on the direction of cell migration, the direction of
the net migration vectors for each cell in 4 separate devices (>300 tracks per condition)
were plotted in polar histograms (Figure 51C). Flow induced a dramatic increase in the
fraction of cells migrating upstream, while treatment of cells with paxillin siRNA
reversed the directional bias, causing more cells to migrate downstream than upstream
(Figure 51C). The difference between the fraction of cells migrating upstream and the
fraction migrating downstream was calculated for each device, and flow caused a
significant increase in the relative fraction of cells migrating upstream (from -
0.088±0.079 to 0.289±0.0294 with flow, Figure 51D). Paxillin was required for the
upstream migration bias, with paxillin siRNA causing a significant decrease in the
relative fraction migrating upstream with flow (-0.165±0.047), and in fact, a net
downstream migration bias is observed with flow and paxillin siRNA (Figure 51 D).
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Figure 51. IF induces paxillin-dependent rheotaxis. A) Sample migration tracks demonstrate upstream migration over
8hrs when exposed to flow. Migration tracks with a net upstream displacement are colored red, and downstream tracks
are black (for clarity, only tracks from cells that migrated >30pm over 8hrs are shown). B) Treatment with paxillin
siRNA reduces upstream migration. C) Polar histograms of the direction of net displacement for each cell tracked over
8hrs (>300 tracks from 4 devices per condition) demonstrate flow-induced rheotaxis, which is attenuated with paxillin
siRNA. D) Difference between the fraction of cells migrating upstream and downstream for each condition in C)
(mean±SEM, ***p<0.001 calculated by one-way ANOVA).
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Figure 52. IF increases migration directionality but does not affect average migration speed. A)
Directionality (net migration distance normalized by total migration distance) increases with flow, but
when paxillin is silenced, the increase in directionality is attenuated. B) Migration speed is unaffected by
flow or siRNA paxillin treatment (mean±SEM, *p<0.05 determined by one-way ANOVA for 4 devices at
each condition).
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Figure 53. Genistein reduces average migration speed (mean±SEM, **p<0.01 determined by one-way
ANOVA for 3 devices at each condition).
4.9 Discussion
Interstitial fluid flow induces a transcellular gradient in matrix adhesion stress inducing
adhesion activation, cell polarization, and migration towards regions of maximum
adhesion tension (Figure 54). This response is mediated by tension-sensitive 1 integrin
complexes and results from a force balance required to maintain static equilibrium.
Integrins are under maximum tension at the upstream side of the cell (Figure 6), and
tension-induced FA-associated protein localization upstream leads to actin accumulation
and membrane protrusion in the upstream direction, eventually leading to upstream
migration. The trends for directional protrusion extension are strikingly similar to the
trends for the direction of cell migration (Figure 48G & Figure 5 1D), consistent with the
observation that protrusion formation is a marker for 3D motility of MDA-MB-231
cells( 198).
Here, we provide evidence for a paxillin-dependent mechanism by which focal adhesion
activation leads to protrusion formation and migration in porous media (Figure 6). Actin
localization upstream requires paxillin and tyrosine kinase activity; vinculin, on the other
hand, remains localized upstream, but the extent of polarization decreases when tyrosine
phosphorylation is inhibited and when paxillin is silenced. These data are consistent with
the observations of Pasapera et al., who demonstrated that vinculin is recruited to FAs by
two separate pathways (111) (Figure 54). In one, tension across r3 1 -integrins is transmitted
to talin, opening cryptic binding domains in talin and allowing vinculin to bind
independent of kinase activity (88,109,110). The second pathway involves tension-
mediated FAK phosphorylation at Y397. This allows for the formation of the FAK/Src
signaling complex and phosphorylation of paxillin at Y31/Y 118, which recruits vinculin
and causes FA maturation (111).
In addition to imparting fluid stresses, IF convects released autocrine factors downstream,
causing gradients of autologously secreted chemokines that have been shown to direct
migration downstream in response to IF (40). Furthermore, it has been shown that these
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autocrine gradients compete with IF fluid stresses, and for MDA-MB 231 cells,
subpopulations that preferentially migrate upstream and downstream emerge when
exposed to flow(49). It has further been shown that at high cell densities, autocrine
chemokine fields overlap with fields from neighboring cells, reducing transcellular
autocrine gradients and inducing preferential upstream migration. In this study, cells were
seeded at a sufficiently high density (6 x 10' cells/ml) and flow rate to minimize
contributions from autocrine gradients, leading to upstream migration. Silencing paxillin,
however, caused cells preferentially to migrate downstream (Figure 51), consistent with
the hypothesis that IF induces simultaneous competing upstream and downstream stimuli.
The nature of the responses to these stimuli, with downstream migration arising from
chemical transport and upstream migration from stress asymmetry, motivate
consideration of chemo-mechanical crosstalk in studying tumor cell migration in the
context of the metastatic cascade (15).
In the present experiments, 4.6 [im/s IF imparts ~1 Pa (1 pN/ pm 2) average stress to the
cell due to the pressure drop across the cell length. Images of collagen matrix obtained
from confocal reflectance imaging, however, demonstrate that only a fraction of the cell
surface is adhered to the local matrix (Figure 42). Estimating that 20% of the cell area
adhered to matrix fibers (fraction of reflectance pixels at cell boundary greater than mean
+ S.D. reflectance intensity in Figure 42), stress at matrix adhesions is amplified to 5
pN/pm 2 stress. This level of stress falls within the range of stresses that have been shown
to activate FAs on 2D surfaces (3-12 pN/ Pm2 induces local actin recruitment in regions of
applied stress via optical trap (200)).
The difference in normal stress across a cell of radius R scales as
or -UO -'R
k
where g is the fluid viscosity, UO is the flow velocity, R is the cell radius and k is the
permeability. Therefore, the same levels of stress asymmetry could be generated with
much lower flow rates in vivo due to the 3 orders of magnitude lower permeability(201),
suggesting that even non-pathologic IF velocities (< I pm/s) would result in an
asymmetry in matrix adhesion tension and promote directional migration.
Although these experiments were conducted on a single cell type, we expect
mechanotransduction of IF stresses to be a generally relevant mechanism that influences
the morphology and function of cells expressing I integrins embedded within tissues
experiencing IF (187). For example, cells in the vicinity of an artery, vein, or lymphatic
vessel are exposed to IF, and the present data suggest that the stresses imparted on these
cells would influence cell morphology and migration. Indeed, basal-to-apical
transendothelial flow has been shown to induce vascular sprouting angiogenesis via
tension between the ECM and basal adhesions, but not when the adhesions are
compressed by apical-to-basal flow (202). In these experiments, the basal cell surface
adheres to collagen via 1 integrins, and basal-to-apical flow generates tension in the
basal 1 integrins, in much the same way that flow generates tension at upstream matrix
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adhesions in the present experiments. Furthermore, basal-to-apical flow induced
phosphorylation of FAK at Y397 and localization of actin to the basal cell surface,
consistent with the effect of IF on tumor cells, and sprouting was inhibited by genistein,
which inhibited cell migration in the present experiments (Figure 53).
Cells experience asymmetric stresses in vivo under various conditions. For example, cell
contraction induces deformation of the local matrix, and this deformation is propagated
through the ECM to neighboring cells (203). For endothelial cells on 2D surfaces,
traction generated by one cell can be transmitted to a neighboring cell inducing
protrusion formation and migration toward the contractile cell (204). These data are
consistent with our observations in 3D that local tension drives protrusion extension and
migration and suggest that stress asymmetries play a role in a variety of cell processes in
vivo. Importantly, in solid tumors, interstitial fluid flow emanates from the vasculature,
and consequently, tumor cells in close proximity to blood vessels will be directed via
rheotaxis toward the leaky vasculature, which is the point of maximum fluid pressure
(205). Therefore, lowering IF velocity magnitude (by reducing IFP(37)) could reduce
tumor cell migration toward vasculature in vivo and render metastatic disease more
treatable.
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Figure 54. Mechanotransduction induces rheotaxis. A) Simulation of flow past the cell in Fig. IC, with
inlet velocity of 4.6pm/s, local fluid velocity vectors in black superimposed on heat map of pressure
(red=max, blue=min). B) Local reaction forces (red=tensile, white=compressive) in cell-matrix
connections required to maintain static equilibrium when exposed to flow profile in A) superimposed on an
image of vinculin distribution. Vinculin localizes to regions of cell-matrix tension. C) Integrin activation by
local flow-induced tension induces vinculin, FAK, paxillin, and actin localization, and subsequent
protrusion extension at the upstream cell membrane. Table. Upstream localization of vinculin is maintained
in the absence of paxillin or when tyrosine kinase activity is blocked, but actin localization and subsequent
protrusion extension, and upstream migration require both tyrosine kinase activity and functional paxillin
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Chapter 5: Conclusions and future work
5.1 Conclusions and contributions
Tumor cell migration is required for the formation of metastases, the formation of which
is the leading cause of death in breast cancer patients (74). Consequently, understanding
the stimuli that induce and guide cell migration and the mechanisms by which tumor cells
transduce the stimuli into a migratory response is critical for developing drugs that
interfere with cell migration and prevent the formation of metastases (15). As a tumor
grows in mass and progresses toward a metastatic phenotype, leaky blood vessels,
osmotic gradients, solid stress, and collapsed lymphatic vessels within the tumor (20)
contribute to increased interstitial fluid pressure at the tumor core. The pressurized fluid
is drained by lymphatic and venous vasculature in the peritumoral stroma, and thus
significant pressure gradients develop at the tumor margin (21). These pressure gradients
drive fluid flow that emanates from the tumor core (25). In this thesis, we explore the
effects of this interstitial fluid flow on tumor cell migration.
Specifically, we take a reductionist approach to isolate the effect of IF on individual
metastatic breast cancer cells (MDA-MB 231). To generate repeatable and robust IF
through physiologically relevant 3D ECM, we developed a microfluidic platform,
modified from previous platforms for investigating angiogenesis (162). The platform
allowed for the generation of IF at physiologic velocities (validated for 0.3um/s-10um/s,
and monitoring of the tumor cells in real time. IF caused cells to elongate and align to
flow streamlines, consistent with the observation that endothelial cells alter morphology
and align to shear stresses similar to those in capillary vessels in vivo (174). IF
dramatically influenced the migration of tumor cells, with cells migrating along
streamlines in the upstream or downstream direction. To investigate the mechanisms that
lead to preferential upstream or downstream migration, we explored the chemical and
mechanical stimuli imparted by flow on tumor cells.
IF alters the local transport environment, and convective transport induces Peclet-#-
dependent gradients in soluble factors secreted by tumor cells (Figure 22). For isolated
cells that secrete the chemokine CCL21 and the cognate receptor CCR7, these gradients
can induce asymmetric receptor binding and activation, with more receptors activated on
the downstream side of the cell (Figure 22), which induces chemotaxis downstream. This
autologous chemotaxis, described by Shields et al. (40), drives tumor cell migration when
autocrine gradients are unaffected by neighboring. However, when cell density is
increased or autocrine receptors are blocked, the effect of autocrine chemokine gradients
is attenuated, and cells no longer preferentially migrate downstream. In fact, the
migration direction is reversed, and cells migrate upstream.
In addition to altering transport environment, IF imparts fluid stresses on cells. These
stresses must be balanced by matrix adhesion tension to maintain static equilibrium, and
thus flow induces asymmetric matrix adhesion stress with greater tension in adhesions on
the upstream side of the cell. For MDA-MB 231 cells in collagen I, these matrix
adhesions are principally comprised of tension-sensitive 1 integrins. Therefore, FA
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complexes at the upstream side of the cell are activated and this activation is propagated,
through paxillin and FAK, to induce protrusion formation and eventual migration
upstream (Figure 54). This upstream migration, called rheotaxis, has been observed in
other cell types (184,206,207), but the data contained in this thesis are the first to suggest
asymmetry in matrix adhesion stress, caused by IF drag, induces rheotaxis.
Autologous chemotaxis, mediated by chemical transport, and rheotaxis, mediated by fluid
stresses, compete to direct cell migration downstream or upstream, respectively (Figure
55). At high cell density, rheotaxis dominates and cells migrate upstream, while at low
cell density, autologous chemotaxis dominates and cells migrate downstream.
Furthermore, these stimuli act independently: at high density, interfering with FA-
signaling allows autologous chemotaxis to direct cell migration downstream, and at low
density, interfering with CCR7 allows rheotaxis to direct cell migration upstream.
Therefore, for each cell in a population, the two stimuli compete, and the local
microenvironment (magnitude of stresses and autocrine gradients), determines which
stimulus will dominate to direct cell migration (Figure 55). The premise that each stimulus
competes to direct migration for each cell in a population suggests that if cells are
dispersed within an ECM with some heterogeneity in the distance between each cell and
the neighboring cells, some cells will migrate upstream via rheotaxis and others will
migrate downstream via autologous chemotaxis, depending on the local
microenvironment (see upper left cell vs. lower left cell in Figure 33A. Indeed, in recent
experiments, Haessler et al. identified subpopulations of cells that migrate upstream and
subpopulations that migrate downstream within a population of MDA-MB 231 cells
exposed to IF.
In summary, we developed a microfluidic device to apply IF to metastatic breast cancer
cells. By implementing this device, we validated CCR7 autologous chemotaxis as a
mechanism that causes downstream migration in response to IF. Furthermore, we
established cell density and IF speed as key parameters in determining the sensitivity of
cells to autocrine gradients and their propensity to migrate via autologous chemotaxis.
Finally, we identified rheotaxis as a novel mechanism for migration in response to IF.
Although the mechanism underlying rheotaxis, namely FA activation and associated
signaling, has been characterized previously, we are the first to demonstrate that this
mechanotransduction mechanism can arise from asymmetry in matrix adhesion stress and
that such stress asymmetry can be induced by IF. Interstitial flow is just one of many
biochemical and biophysical stimuli in vivo that influences tumor cell migration, but its
consideration is crucial for understanding and treating metastatic disease.
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Figure 55. Rheotaxis and autologous chemotaxis compete to determine the direction of cell migration in
response to IF. At high cell density, rheotaxis dominates, and cells migrate upstream, and at low cell
density, autologous chemotaxis dominates and cells migrate downstream. However, at high cell density,
interfering with paxillin allows autologous chemotaxis to dominate, and at low cell density, interfering with
CCR7 allows rheotaxis to dominate.
5.2 Implications
The tumor microenvironment and escape radius
Interstitial flow has been studied extensively with regard to drug transport for cancer
treatment (208), and in vivo it has been shown that interstitial fluid pressure (IFP) is
correlated with cervical cancer patient survival (24) and reducing interstitial fluid
pressure reduces tumor cell proliferation (37). Because interstitial fluid flows from a
tumor to surrounding lymphatics or the low-pressure veins, blocking CCR7 and thus
inhibiting migration in the flow direction would reduce migration from the tumor and
likely reduce the probability of metastasis formation. Cell density and interstitial flow
rates decrease with increasing distance from the tumor, both of which are highest at the
tumor margin. Since high cell density and high flow rates both favor upstream migration,
our data suggest the existence of an "escape radius" at a critical distance from the tumor
surface (
Figure 56). For cells at a radial distance less than the escape radius, interstitial flow guides
cells upstream, keeping cells clustered with the tumor, and inducing migration toward
high-pressure tumor vasculature. These data suggest that high density cells would migrate
toward high-pressure arterial vasculature rather than venous vasculature. For cells located
beyond the escape radius, interstitial flow guides cells downstream, toward draining
lymphatics or veins. Although further modeling and in vivo data are required to validate
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this hypothesis, the escape radius could be a critical parameter in estimating the severity
of metastatic disease and determining proper treatment.
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Figure 56. The competing nature of autologous chemotaxis and rheotaxis suggest the existence of an
escape radius within the tumor microenvironment. High cell density and flow rates favor rheotaxis,
inducing migration toward tumor-associated blood vasculature. However, low cell density and lower flow
rates favor autologous chemotaxis, driving cells toward draining lymphatics.
3D durotaxis
We demonstrate that paxillin is required for directional protrusion and rheotaxis, which is
consistent with the observation that paxillin is required for protrusion toward regions of
maximum adhesion tension on 2D substrates (126). It is also known that phosphorylated
paxillin enhances lamellipodial activity for cells on 2D substrates (209), and importantly,
the FAK/paxillin/vinculin signaling axis is instrumental in durotaxis (104). Consequently,
the mechanism and relevant signaling pathways responsible for rheotaxis in 3D ECM
may be similar to the mechanism underlying durotaxis for cells on 2D substrates, where
cells migrate in response to gradients in matrix adhesion tension that result from myosin-
dependent cell contraction on substrates with a gradient in mechanical stiffness (118).
Cells exert greater force against a stiff substrate than a soft one (118), so the normal
stresses are higher against a stiff ECM, causing migration in the direction of the stiffer
matrix. Therefore, the mechanism underlying rheotaxis and durotaxis may be the same,
where stress asymmetry at matrix adhesions induces migration toward adhesions under
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Figure 57. The role of matrix adhesion stress asymmetry suggests similar mechanisms are responsible for
rheotaxis and durotaxis. A-B) IF imparts net downstream downstream drag force on cells exposed to IF,
while gradients in substrate stiffness induce greater cell traction on stiffer regions of the substrate. C) The
reaction stresses required to maintain static equilibrium in response to IF and the increased traction
generated on stiffer substrates cause asymmetry in matrix adhesion stress. D) The gradients in matrix
adhesion stress direct FAK- and paxillin-dependent rheotaxis and durotaxis.
5.3 Future research directions
EMT
Though we have discussed the effects of IF stresses in the context of tumor cell migration
and rheotaxis, we expect these stresses to influence the epithelial-to-mesenchymal
transition in vivo. The FAK/Src signaling axis is a critical regulator of EMT in solid
tumors (55,210), and FAK catalytic activity was required for down regulation of E-
cadherin in colon cancer cells (211). Furthermore, IF velocity magnitude (27) and
interstitial fluid pressure (37) increase with solid tumor progression, and we demonstrate
that these increases in pressure and fluid velocity stimulate FAK phosphorylation at
Y397, which has been shown to promote Src binding to FAK and activation of the
Src/FAK signaling complex (212), which subsequently drives cells toward a
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mesenchymal (211), motile (213), metastatic phenotype (92), and flow has been shown to
stimulate EMT in ovarian cancer (214). Therefore, IF is a critical stimulus in the
metastatic cascade, and lowering IF velocity magnitude (by reducing IFP (37)) could
reduce tumor cell migration in vivo and render metastatic disease more treatable.
Computational analysis of stress distribution
The analysis for IF stresses imparted on tumor cells is largely based from analytical
solutions to Brinkman's flow past a sphere (188) and 2D simulations on geometries
generated from confocal microscopy data (Figure 54). However, to better understand the
full 3D stress profile, a computational simulation including a full 3D representation of the
cell, matrix, and matrix adhesions must be developed. By representing the full cellular
structure and associated matrix as a 3D computational domain (i.e./ finite element mesh),
we could simulate fluid stresses and local chemokine gradients on a single cell. Such
single-cell simulations could then be incorporated into a device-level simulation, and full
experiments within microfluidic devices could be simulated to provide insight into the
local mechanisms that guide cell migration and to verify that local gradients and stresses
compete to determine the direction of cell migration in response to IF.
We were able to generate a full 3D mesh for cells imaged with confocal microscopy
(Figure 58); however, modeling representing the matrix in a computational model
presented more of a difficulty (Figure 58). Matrix fibers are of the same diameter (fractions
of a micron) as the optical resolution of our confocal system, which rigorous
representation of fibers in 3D. However, there are a few strategies for overcoming this
limitation, including: 1) Imaging with higher magnification, high NA objective (100x).
However, improved resolution comes at the cost of cytotoxicity. Live imaging, which
would be required for any sort of traction force microscopy, would be very difficult due
to high-power excitation. 2) Alternative strategies for reconstructing fibrous material.
Rather than fitting surfaces to each collagen fiber, we assume a distribution of fiber
diameters based on electron microscopy (EM) data. We then implement a fit process of
ID lines that follow collagen fibers and subsequently dilate these lines so the distribution
of fiber diameters is similar to what has been measured by EM. Although method 2 is
less rigorous than creating computational objects for each fiber independently, it does not
require extra hardware and would vastly improve on continuum models.
Certainly much effort would be required to develop such a computational model, but
there are many potential applications for such a method. For example, Representing the
collagen fibers computationaly would allow videos of matrix deformation to be converted
to displacement data, and by implementing the appropriate consitituive law (a nontrivial
task in itself), a label-free 3D traction force microscopy method could be developed from
confocal reflectance imaging. Because the in vivo ECM is fibrous and porous, rigorous
modeling of ECM mechanics is required for fully understanding mechanotransduction
and the force landscape of 3D mesenchymal migration.
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Figure 58. Approaches for representing confocal imaging data as computational FEM domains. A) 3D
reconstruction of a full z-stack of images for immunofluorescence-labeled vinculin. B) Using a 3D edge
detection and surface-fitting algorithm, the fluorescence images can be converted to a FEM mesh. C)
Confocal reflectance image of the pericellular matrix for the cell in (A). D) Though surface-fitting
algorithms recapitulate some elements of the matrix in (C), fibers are artificially dilated in z due to
insufficient optical resolution, and the close proximity of fibers creates an artifact whereby the
computational domain is characterized by more crosslinks among matrix fibers than the actual matrix.
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Appendix A - Cell seeding protocol*
Material
[Software]
1. cells in flasks
2. media (for preparing cell suspension and for filling device channels)
3. trypsin
4. 1x PBS without calcium or magnesium
5. Collagen gel solution (substitute PBS for DMEM*)
[Hardware]
1. collagen-coated flasks (if further plating is desired)
2. 15ml falcon tube
3. 1.5ml centrifuge tube
Procedure
1. Have 200ul of lOX DMEM Collagen gel ready^ (9>pH>7.4).
2. Prepare cell suspension at desired concentration (will be diluted 1/10 times, 20ul
cell suspension in 200ul collagen gel)
3. Place cell suspension on ice for chilling for 5 minutes (required for avoiding pre-
polymerization of collagen gel suspension)
4. Add 20ul of pre-chilled cell suspension (make sure that cell pellet was broken-
single cell suspension required) to the collagen gel and pipette for 30sec (4-5times
and gently stir, using a larger pipette tip will reduce shear stress and increase
viability). When sucking up cells-in-gel suspension make sure to place the pipette
tip in the middle of the 1.5ml eppendorf tube in order to collect a well-mixed
cells-in-gel suspension (avoid sucking up solution from the bottom of the
eppendorf tube as it will result in a lower cell seeding density, and mix until cells
are distributed uniformly).
5. Cells in Collagen gel solution is ready to be microinjected or filled in gel filling
ports. Inject/Fill in the devices and place in the humidified chamber to allow
polymerization at 37C. (Don't have the humidified chamber sit in the hood for
more than 5minutes)
6. Add media to device channels after polymerization. Add media carefully (use
long 200ul pipette tips) to avoid bubbles in the channels. Aspirating bubbles from
channels can result in separation of coverslip from device.
Notes.
1. Use DMEM preferentially for obtaining cell viability in gel suspension. lOX PBS
solutions may also work.
2. MDA23 1 Cells are not viable in pH 7.0, Have tested pH>7.4-9
3. Make sure to aspirate all supernatant, as trypsin may result in a sparser, weak gel
4. Return filled devices to incubator quickly. Leaving filled devices in the hood
(even if they're in humidity boxes) while filling others can result in lower cell
viability.
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5. Don't leave devices in the incubator to polymerize for longer than necessary. The
gel will dry out if the channels aren't filled with media, and this will increase cell
death.
If only passing cells, after step 7, simply transfer lml (for T25) and 3ml (for T75) to a
new collagen-coated flask. Add 4ml (for T25) and 12ml (for T75) of fresh media. Place
new flask in the incubator. Change media every other day.
If cells do not detach after waiting for 2-5 minutes, then wash with PBS and add
trypsin again. This may occur when the cells have become overconfluent (YZ,
11/12/07)
Potential problems
1. Fibrils bundle up resulting in a nonhomogeneous gel
Microinjection device 3 Channel gel filling (DMEM-based gels)
Possible reasons:
o Prepolymerization of collagen gel:
- while adding cell suspension (if using warm medium)
* while preparing collagen gel and mixing (due to local pH
variation)
Precautions:
o Be sure to add cell/gel solution quickly. If the solution is added slowly, it
can prepolymerize in the pipette tip. This can cause bundles of fibers like
those in Figure 2 above.
o This is a particular problem for microinjection as the large surface area of
the metal needle can cause the gel solution to reach room temperature
rapidly. One solution is to use 2 needles when microinjecting. Keep one
needle on ice while using the other to microinject, and switch neeldles for
the next device. Also, be sure to rinse the needles with COLD water
between injections.
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2. Low cell viability and black speckles appear in the collagen gel
Resuidual salt from PDL coating can lead to cell
death
Possible Causes:
o After PDL coating devices, they must be rinsed with water (NOT PBS)
and dried in the oven for -36hrs. If the devices are not well rinsed,
residual salts from the PDL coating will result in very low viability, and
black speckles in the collagen gel
3. Inhomogeneous distribution of cells in devices (# of cells in each device varies)
Possible causes:
o Collagen gel and cell suspension mixed poorly
- When adding cells to gel be sure to mix until cells are homogenous
o Cells settled during device filling
* Be sure to periodically mix the collagen gel and cell suspension so
cells do not accumulate at the bottom of the eppendorf tube
4. Leaking of media between PDMS and coverslip
Possible causes:
o The PDMS was incorrectly plasma treated, or recovered hydrophobicity
after plasma treatment.
o The devices were not handled carefully during seeding.
o The coverslip or PDMS surface were not properly cleaned (even tiny dust
particles can lead to separation of the coverslip)
o Gel solution was not carefully added and wetted the surface between the
PDMS and coverslip
Comments:
o There is an optimal time to wait after plasma treatment, and this time is
characteristic to each device. For example, the thin channel microinjection
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device should be seeded Ilhr after plasma treatment. However, the biopsy
device should be seeded 1.5-2hrs after plasma treatment.
o Plasma treatment renders the PDMS hydrophilic which is desirable for
coverslip fusion. However, the PDMS recovers its hydrophobicity with
time, and hydrophobicity is desired to contain the gel in the region of
interest during seeding which prevents leaking onto the surface between
the PDMS and coverslip.
o Consequently, if leaking is a problem, consider changing incubation time
after plasma treatment in order to maximize bond-strength between the
PDMS and coverslip while preventing wetting of the PDMS-coverslip
interface.
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Appendix B - Tracking microparticles for verifying IF field
Governing equations:
Brinkman's equation provides a fluid momentum balance for flow through a porous
medium of hydraulic conductivity K:
V - -v -VP=O [1]
K
In the limit of small pore size or large length scale, where L >> - ttK, [1] reduces to
Darcy's law:
v = -KVP [2]
Method:
1) Determine appropriate microsphere size and concentration. Iteration is often
required for both size and concentration of the microspheres. The nominal
diameter of the microspheres must be smaller than the pore size of the gel to
allow the beads to flow through the gel, and the concentration must be small
enough to allow tracking of individual beads. For 2mg/mi collagen gel
polymerized at pH 8.9, 200nm diameter beads at 1 x 10 4 beads/ml is optimal.
2) Attach fluid reservoirs to media ports of device. To assume steady pressure
gradient, ensure that the cross-sectional area of the reservoirs is much larger than
the cross-sectional area of the gel-region of the device.
3) Dilute the microspheres to the appropriate concentration and add the suspension
to the upstream and downstream reservoirs. Measure the relative difference in
fluid head height between the upstream and downstream reservoirs to determine
the pressure gradient across the gel.
4) Acquire time-lapse images of the microspheres traveling through the gel at a
known pressure gradient.
5) Use particle-tracking software (ie/ Imaris), to track the microspheres in the
acquired timelapse image sequence.
6) Compare individual particle tracks and measure the velocity variance to determine
gel heterogeneity.
7) If the variance of individual tracks is small and the length scales are large
compared to the pore size of the gel, average the velocity vectors and use [2] to
determine the hydraulic conductivity.
8) If the length scales are small, use FEM software to solve [1] for the geometry of
the hydrogel being measured, and compare individual measured microsphere
velocity vectors to those predicted by the FEM model.
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Appendix C - MDA-MB 231 Passage Protocol
Purpose:
Transfer subpopulation of cells from a confluent flask (parent culture) to a new culture
flask (daughter culture) to maintain healthy cell phenotype. Note that each passage
artificially selects subpopulations of cells, and certain cell types (such as endothelial
cells) will lose their characteristic phenotype at high passage numbers; therefore, it is
important to keep track of the passage number.
Materials:
1. New culture flask (typically T25 flasks are used)
1 flask per daughter culture
2. 15mL falcon tube
1 tube per parent culture
3. Cold cell culture media
lOmL per parent culture
4. Warm PBS
5mL per parent culture
5. Warm trypsin
ImL per parent culture
6. Warm media
5mL per daughter culture (if using T25 flasks for daughter culture)
Procedure:
1. Incubate PBS, trypsin, and media to 37 0C
2. Aspirate media from parent culture using Pasteur pipette and vacuum tube
3. Wash parent culture with warm PBS
4. Aspirate PBS with Pasteur pipette
5. Add 1 mL of warm trypsin to parent culture
6. Transfer parent culture flask with trypsin to incubator
7. Incubate trypsin and cells for 2min
8. Check that cells have been successfully lifted from flask surface
If cells are still adhered, gently tap the flask to dislodge cells
9. Add ImL of cold media to trypsinized cells
10. Transfer 2mL (trypsin + cells + cold media) to falcon tube
If counting cells: transfer 20RL to 20pL trypan blue
11. Add 8mL cold media to falcon tube to bring total volume to IOmL
12. Centrifuge for 5min at 1.2e3 RPM
13. Aspirate supernatant with Pasteur pipette
14. Re-suspend cell pellet in lmL of warm media
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15. Transfer 200ptL of cell/media suspension to daughter flask
16. Add 5mL of warm media to each daughter flask
17. Aspirate remaining cell/media suspension from falcon tube before disposal
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Appendix D - MMP Inhibition with Aprotinin
Sources:
1. (Davis et al. JCS 2000) - Endothelial cells
2. (Ntayi et al. Exp. Cell. Res. 2001) - Melanoma invasion in 3D collagen I
3. (O'Cearbhaill et al. Ann. Biomed. Eng. 2010) - Source for concentration ranges in
medium
4. (Yeon et al. Lab Chip 20012) - Source for mixing aprotinin in collagen gel
Reagents
1. Aprotinin - Sigma: Al 1532.
2. Standard collagen I gel reagents:
a. NaOH
b. DI water
c. lOx DMEM
d. Rat tail collagen in acetic acid
Protocol
1. Dilute aprotinin to 2 U/ml directly in lOx DMEM2. Prepare gel by standard
protocol with aprotinin DMEM ie/
a. 20[tL lOx DMEM w/ 2 U/mL aprotinin
b. 10.5gL 0.5 N NaOH
c. 58pL DI-water
d. I11 pL 3.60 mg/ml collagen I
2. After collagen gel polymerization, add medium with 10 U/ml aprotinin
3. Continue to culture with 10 U/ml aprotinin
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Appendix E - Blocking Integrins
Product: anti-integrin beta 1 antibody [P5D21 ab24693 - Abcam
Sources:
Ahmed et al. Clinical & Experimental Metastasis 2005
Preliminary titration experiment:
24-well plate with 5 concentrations (0,1,2,5,10ug/ml). 5ug/mi interfered with cell
adhesion to glass coated with type I collagen (Fig. 1), and lOug/ml results were similar to
5ug/ml.
Fig. 1 MDA-231 plated on collagen type 1 coated glass for titrating betal-integrin
blocking antibody. A) Cells 90min after plating with Oug/ml ab2693. B) Cells 90min
after plating with 5mg/ml ab2693. Note: 10ug/ml shows no improvement over 5ug/ml &
cells adhere and spread with 5mg/ml over 24hrs if media is not replenished every 6hrs.
Protocol 1:
- Advantage: requires less reagent, many experiments per stock antibody
- Disadvantage: does not completely block cell-matrix interactions. although cells spread
much less than control, there is some matrix interaction as evidenced by vinculin, beta-b
colocalization at matrix connections
1.
2.
3.
Resuspend stock ab2693 and aliquot into 100Il at 100pg/ml
For experiment, dilute aliquot in growth medium to final concentration of 5pg/ml
Prepare cell-gel solution following standard protocol (see 2WJP16A)
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4. After collagen gel polymerization, add culture medium with 5[tg/ml blocking
antibody
Notes:
- To verify anti-beta I blocking, fix cells with 4% PFA, and incubate 2hrs with goat anti-
mouse secondary antibody (ab2693 is ms mAb).
- Because blocking medium is added after polymerization, cells have a chance to form
matrix adhesions initially
Figure 2. Reflectance, vinculin, and anti-betal after 24hrs following protocol 1. Note
colocalization of betal and vinculin in fig IA & IB. Also note small protrusions visible
in the anti-betal channel.
Protocol 2:
- Advantages: Totally blocks matrix adhesions. Cells remain perfectly spherical. Effects
- Disadvantages: Intense reagent use. Only 3-4 expts (defined as sessions of cell seeding)
per vial
1. Resuspend stock ab2693 at 50g/ml
a. Note: This solution will be used to resuspend cells after centrifugation
prior to mixing with collagen during cell seeding. Therefore aliquot the
50pg/ml as appropriate (on 6WJP14, 500g1 aliquots were prepared so that
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3e6 cells could be resuspended at 6e6 cells/ml to be diluted lOx in
collagen gel yielding 6e5 cells/ml in 5 jg/ml containing gel).
2. Aliquot and freeze in appropriate volumes, leaving at least 50 g for creating
blocking medium
3. Remaining 50 g or more should be aliquoted according to protocol I for making
5gg/ml blocking antibody in growth medium.
4. Lift, count, and centrifuge cells following standard protocol (2WJP16A)
5. Resuspend cell pellet at 6e6 cells/ml in 50 g/ml anti-betal blocking antibody
medium (from step 1)
6. Prepare 200 l collagen gel solution
7. Dilute 20jl of cell/medium solution from step 3 (6e6 cells/ml in 50 g/ml) in
200 l collagen gel solution for a cell/gell suspension containing 5 jg/ml blocking
antibody
8. Inject gel and allow to polymerize for 20min
9. Hydrate gel with 5 jg/ml blocking antibody growth medium solution
Notes:
- Effects compared v. protocol 1 are marginal. Sample vinculin image provided in
Fig. 3. Vinculin remains totally isotropic
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